George Klein
#21,983
Most Influential Person Now
Hungarian/swedish biologist
George Klein 's AcademicInfluence.com Rankings
Download Badge
Biology
Why Is George Klein Influential?
(Suggest an Edit or Addition)According to Wikipedia, George Klein was a Hungarian–Swedish microbiologist and public intellectual. Specializing in cancer research, he was professor of tumour biology at the Karolinska Institute in Stockholm from 1957 to 1992, a chair created for him, and as professor emeritus continued to work as research group leader in the microbiology and tumor biology center. According to Nature, the department Klein founded was "international and influential". In the 1960s he and his wife, Eva Klein, "laid the foundation for modern tumour immunology".
George Klein 's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines (1973) (1640)
- Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx (1970) (1179)
- Inhibition of antigen processing by the internal repeat region of the EpsteinBarr virus nuclear antigen-1 (1995) (884)
- Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. (1968) (812)
- Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. (1960) (806)
- Characteristic chromosomal abnormalities in biopsies and lymphoid‐cell lines from patients with burkitt and non‐burkitt lymphomas (1976) (800)
- Evolution of tumours and the impact of molecular oncology (1985) (676)
- The role of gene dosage and genetic transpositions in carcinogenesis (1981) (613)
- Suppression of Malignancy by Cell Fusion (1969) (589)
- Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men (1983) (490)
- SURFACE MARKERS ON HUMAN B AND T LYMPHOCYTES (1973) (481)
- The approaching era of the tumor suppressor genes. (1987) (471)
- Expression of Epstein‐Barr virus‐encoded proteins in nasopharyngeal carcinoma (1988) (448)
- Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. (1969) (443)
- Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. (1970) (413)
- EB virus-induced B lymphocyte cell lines producing specific antibody (1977) (364)
- Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro (1977) (356)
- The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV (1971) (350)
- Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma. (1975) (350)
- Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. (1988) (337)
- EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. (1993) (326)
- Demonstration of two distinct components in the early antigen complex of epstein‐barr virus‐infected cells (1971) (323)
- Establishment in continuous culture of a new type of lymphocyte from a “burkitt‐like” malignant lymphoma (line d.g.‐75) (1977) (299)
- ANTIGENIC PROPERTIES OF LYMPHOMAS INDUCED BY THE MOLONEY AGENT. (1964) (293)
- Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. (1974) (293)
- Sensitivity of Epstein‐Barr virus (EBV) producer and non‐producer human lymphoblastoid cell lines to superinfection with EB‐virus (1972) (292)
- Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virus (1990) (291)
- Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. (1966) (288)
- Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. (1979) (284)
- p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. (1994) (279)
- Association of Epstein-Barr virus with thymic carcinoma. (1985) (269)
- Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. (1991) (264)
- Relationship between Epstein‐Barr virus (EBV) DNA and the EBV‐determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies (1974) (263)
- Epstein-Barr virus strategy in normal and neoplastic B cells (1994) (258)
- Viral latency and transformation: The strategy of Epstein-Barr virus (1989) (242)
- Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non‐immunized semi‐syngeneic mice against a mouse lymphoma line (1975) (238)
- The analysis of malignancy by cell fusion. I. Hybrids between tumour cells and L cell derivatives. (1971) (229)
- The Epstein-Barr virus and neoplasia. (1975) (223)
- Tumorigenicity of human hematopoietic cell lines in athymic nude mice (1977) (213)
- Transplantation of Polyoma Virus-induced Tumors in Mice (1961) (211)
- Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. (1987) (208)
- Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line. (1993) (206)
- A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1 (1995) (204)
- Burkitt lymphoma. (2005) (203)
- Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. (1993) (199)
- Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential. (1993) (188)
- EBV‐determined nuclear antigen (EBNA)‐positive cells in the peripheral blood of infectious mononucleosis patients (1976) (183)
- Epstein-Barr virus susceptibility of normal human B lymphocyte populations (1984) (183)
- p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain. (1995) (181)
- gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor. (1985) (178)
- Nonrandom chromosome changes involving the Ig gene-carrying chromosomes 12 and 6 in pristane-induced mouse plasmacytomas (1979) (178)
- Epstein‐Barr virus (EBV)‐associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease (1970) (176)
- The Relationship of the Virus to Nasopharyngeal Carcinoma (1979) (176)
- YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage. (1985) (173)
- Conditioned tumorigenicity of activated oncogenes. (1986) (171)
- Comparative studies of mouse tumors with respect to their capacity for growth as “ascites tumors” and their average nucleic acid content per cell (1951) (170)
- Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution. (1977) (168)
- Epstein–Barr virus infection in humans: from harmless to life endangering virus–lymphocyte interactions (2007) (168)
- Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid (1976) (167)
- Surface Markers on Human B and T Lymphocytes (1976) (166)
- Relationship between the Epstein‐Barr virus and undifferentiated nasopharyngeal carcinoma: Correlated nucleic acid hybridization and histopathological examination (1977) (166)
- RELATION BETWEEN EPSTEIN-BARR VIRAL AND CELL MEMBRANE IMMUNOFLUORESCENCE OF BURKITT TUMOR CELLS (1968) (160)
- Phenotypic and cytogenetic characteristics of human B-lymphoid cell lines and their relevance for the etiology of Burkitt's lymphoma. (1982) (159)
- IMMUNOGLOBULIN AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE AS MARKERS OF CELLULAR ORIGIN IN BURKITT LYMPHOMA (1973) (157)
- Membrane immunofluorescence reactions of Burkitt lymphoma cells from biopsy specimens and tissue cultures. (1967) (156)
- Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus. (1970) (147)
- Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. (1987) (146)
- Relationship between the sensitivity of EBV‐carrying lymphoblastoid lines to superinfection and the inducibility of the resident viral genome (1973) (145)
- Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland Eskimoes. (1982) (140)
- Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation. (2001) (139)
- Resistance of polyoma virus immunized mice to transplantation of established polyoma tumors (1961) (138)
- Cell-mediated cytotoxicity for bladder carcinoma: evaluation of a workshop. (1975) (138)
- Epstein-Barr virus-associated antibody patterns in carcinoma of the post-nasal space. (1969) (136)
- Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vγ9/Vδ2 T cells in tumor immunity (1997) (135)
- The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus. (1989) (134)
- Biological differences between Epstein-Barr virus (EBV) strains with regard to lymphocyte transforming ability, superinfection and antigen induction. (1975) (133)
- Growth and antigenic properties of a biopsy‐derived Burkitt's lymphoma in thymus‐less (nude) mice (1973) (131)
- The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies (1996) (130)
- Tumor-specific transplantation antigens: G. H. A. Clowes memorial lecture. (1968) (129)
- Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53. (1993) (128)
- Association of SV40 with human tumors (2002) (127)
- Antibodies to early Epstein-Barr virus-induced antigens in Burkitt's lymphoma. (1971) (126)
- Surface markers on human B‐ and T‐lymphocytes. IX. Two‐color immunofluorescence studies on the association between EBV receptors and complement receptors on the surface of lymphoid cell lines (1976) (126)
- Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in the prototype NK target YAC-1. (1998) (120)
- Oncogene Amplification in Squamous Cell Carcinoma of the Oral Cavity (1989) (119)
- Large-scale hypomethylated blocks associated with Epstein-Barr virus–induced B-cell immortalization (2014) (116)
- Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57BL mice (1988) (116)
- Oncogene activation and tumor progression. (1984) (116)
- Correlation between Humoral Antibody and Regression of Tumours induced by Feline Sarcoma Virus (1971) (115)
- Myc/Ig juxtaposition by chromosomal translocations: some new insights, puzzles and paradoxes. (1985) (114)
- Long-term survival of patients with Burkitt's lymphoma: an assessment of treatment and other factors which may relate to survival. (1967) (114)
- Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma. (1992) (113)
- Clonal origin for individual Burkitt tumours. (1970) (112)
- Intracellular forms of Epstein–Barr virus DNA in human tumour cells in vivo (1976) (112)
- Burkitt’s Lymphoma Is a Malignancy of Mature B Cells Expressing Somatically Mutated V Region Genes (1995) (111)
- Activation of the epstein‐barr virus genome by 5‐aza‐cytidine in latently infected human lymphoid lines (1981) (110)
- Interferon gamma induces lung colonization by intravenously inoculated B16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens. (1987) (109)
- Chromosome changes (trisomies #15 and 17) associated with tumor progression in leukemias induced by radiation leukemia virus. (1978) (109)
- Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue. (1994) (108)
- Variation of antigenic characteristics between different mouse lymphomas induced by the Moloney virus. (1966) (108)
- Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas (2004) (108)
- The analysis of malignancy by cell fusion. 3. Hybrids between diploid fibroblasts and other tumour cells. (1971) (106)
- Selection of an immunoresistant Moloney lymphoma subline with decreased concentration of tumor-specific surface antigens. (1968) (106)
- Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients. (1997) (105)
- Human herpesvirus-8-encoded LNA-1 accumulates in heterochromatin- associated nuclear bodies. (1999) (104)
- Studies on resistance against 5-fluorouracil. I. Enzymes of the uracil pathway during development of resistance. (1962) (104)
- An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins. (1993) (102)
- Elevated c-myc expression facilitates the replication of SV40 DNA in human lymphoma cells (1987) (102)
- Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes. (2010) (101)
- Antibody reactions to virus-specific early antigens (EA) in patients with cytomegalovirus (CMV) infection. (1974) (100)
- Antibody to feline oncornavirus‐associated cell membrane antigen in neonatal cats (1971) (100)
- Production by EBV infection of an EBNA‐positive subline from an EBNA‐negative human lymphoma cell line without detectable EBV DNA (1975) (99)
- Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinomas. (1995) (98)
- CONVERSION OF SOLID NEOPLASMS INTO ASCITES TUMORS (1955) (98)
- Epstein-Barr-virus-carrying lymphoma in a patient with ataxia-telangiectasia. (1981) (98)
- Chromosomal translocations activating myc sequences and transduction of v-abl are critical events in the rapid induction of plasmacytomas by pristane and abelson virus (1984) (98)
- Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity. (1986) (97)
- RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies. (2004) (97)
- Demonstration of host resistance against isotransplantation of lymphomas induced by the Gross agent. (1962) (96)
- The analysis of malignancy by cell fusion. V. Further evidence of the ability of normal diploid cells to suppress malignancy. (1974) (95)
- Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate (1980) (95)
- Studies on the effect of x-rays on the biochemistry and cellular composition of ascites tumors. I. Effect on growth rate, cell volume, nucleic acid and nitrogen content in the Ehrlich ascites tumor. (1954) (94)
- High‐throughput live‐cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts (2011) (94)
- The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest. (1995) (94)
- Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas. (1994) (93)
- Linear association between cellular DNA and Epstein-Barr virus DNA in a human lymphoblastoid cell line. (1973) (93)
- Epstein‐Barr virus‐associated complement‐fixing and nuclear antigens in Burkitt lymphoma biopsies (1974) (93)
- IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines. (2006) (92)
- The action of dna antagonists on epstein‐barr virus (EBV)‐associated early antigen (EA) in burkitt lymphoma lines (1971) (90)
- Possible Enzymic Mechanism for the Development of Resistance against Fluorouracil in Ascites Tumours (1959) (89)
- Association of Epstein–Barr viral genomes with American Burkitt lymphoma (1976) (89)
- Characterization of ebv‐carrying b‐cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth (1987) (89)
- Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma (2000) (88)
- Expression of epstein‐barr virus‐encoded growth‐transformation‐associated proteins in lymphoproliferations of bone‐marrow transplant recipients (1991) (86)
- Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein‐Barr virus transformation of the cells (1978) (86)
- Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line. (1998) (86)
- Intraocular tumor formation of RB reconstituted retinoblastoma cells. (1991) (85)
- Cell type and differentiation dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses. (1992) (85)
- LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription. (2004) (83)
- Rat c-myc oncogene is located on chromosome 7 and rearranges in immunocytomas with t(6:7) chromosomal translocation (1983) (83)
- Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: Antibodies to EBV associated Membrane and Viral Capsid Antigens in Burkitt Lymphoma Patients (1970) (83)
- Cytogenetic mapping of the trisomic segment of chromosome 15 in murine T-cell leukaemia (1978) (82)
- A human RNase E-like activity that cleaves RNA sequences involved in mRNA stability control. (1995) (82)
- Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region (1991) (82)
- Inducibility of the Epstein‐Barr virus (EBV) cycle and surface marker properties of ebv‐negative lymphoma lines and their in vitro EBV‐converted sublines (1976) (82)
- Identification of wild‐type and mutant p53 peptides binding to HLA‐A2 assessed by a peptide loading‐deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay (1994) (82)
- Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti‐MA) (1974) (81)
- Detection of Epstein‐Barr virus DNA in American Burkitt's lymphoma (1976) (81)
- RELATION BETWEEN EPSTEIN-BARR VIRAL AND CELL MEMBRANE IMMUNOFLUORESCENCE IN BURKITT TUMOR CELLS (1969) (80)
- Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays (2012) (80)
- Patterns of antibodies to Epstein-Barr virus-induced early antigens in Burkitt's lymphoma. Comparison of dying patients with long-term survivors. (1973) (78)
- Search for unknown tumor‐antagonizing genes (2003) (78)
- Growth of diploid, epstein‐barr virus‐carrying human lymphoblastoid cell lines heterotransplanted into nude mice under immunologically privileged conditions (1979) (77)
- Epstein-Barr Virus Immortalization of Human B-Cells Leads to Stabilization of Hypoxia-Induced Factor 1 Alpha, Congruent with the Warburg Effect (2012) (76)
- Decreased expression of E‐cadherin and increased invasive capacity in EBV‐LMP‐transfected human epithelial and murine adenocarcinoma cells (1992) (76)
- The estimation of nucleic acids in individual isolated nuclei of ascites tumors by ultraviolet microspectrophotometry and its comparison with the chemical analysis. (1952) (76)
- Antibodies to LMP2A/2B in EBV-carrying malignancies. (1995) (75)
- RELATION BETWEEN EPSTEIN-BARR VIRAL AND CELL MEMBRANE IMMUNOFLUORESCENCE IN BURKITT TUMOR CELLS (1968) (75)
- EBV‐Associated serological patterns in a burkitt lymphoma patient during regression and recurrence (1969) (75)
- Modulation of sensitivity to natural killer cell lysis after in vitro explantation of a mouse lymphoma. (1978) (75)
- Identification of a purified complement-fixing antigen as the Epstein-Barr-virus determined nuclear antigen (EBNA) by its binding to metaphase chromosomes. (1977) (74)
- Epstein-Barr-virus immunity and tissue distribution in a fatal case of infectious mononucleosis. (1978) (74)
- Antigenic properties of other experimental tumors. (1962) (74)
- Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients. (1981) (74)
- Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent (2014) (74)
- SURFACE IgM SPECIFICITY ON CELLS DERIVED FROM A BURKITT'S LYMPHOMA (1967) (74)
- Circulating immune complexes in sera of patients with Burkitt's lymphoma and nasopharyngeal carcinoma (1976) (73)
- In vitro NK‐activity and in vivo resistance to leukemia: Studies of beige, beige/nude and wild‐type hosts on C57BL background (1980) (73)
- Reciprocal 8;14 translocation in EBV‐negative B‐cell acute lymphocytic leukemia with burkitt‐type cells (1979) (73)
- Antibody‐dependent cellular cytotoxicity against epstein‐barr virus‐associated antigens in african patients with nasopharyngeal carcinoma (1978) (72)
- Co-localization of the retinoblastoma protein and the Epstein-Barr virus-encoded nuclear antigen EBNA-5. (1991) (72)
- Chromosomal rearrangements after ex vivo Epstein–Barr virus (EBV) infection of human B cells (2010) (70)
- STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma. (2011) (70)
- Epstein-Barr virus-related antibody patterns in ataxia-telangiectasia. (1979) (70)
- The analysis of malignancy by cell fusion. IV. Hybrid between tumour cells and a malignant L cell derivative. (1973) (70)
- Lung colonization and metastasis by disseminated b16 melanoma cells: H‐2 associated control at the level of the host and the tumor cell (1985) (69)
- Latent nuclear antigen of Kaposi's sarcoma herpesvirus/human herpesvirus-8 induces and relocates RING3 to nuclear heterochromatin regions. (2002) (69)
- Resistance to H-2-restricted but not to allo-H2-specific graft and cytotoxic T lymphocyte responses in lymphoma mutant. (1990) (69)
- Functional Characterization of the Candidate Tumor Suppressor Gene NPRL2/G21 Located in 3p21.3C (2004) (68)
- Search for host defenses in Burkitt lymphoma: membrane immunofluorescence tests on biopsies and tissue culture lines. (1967) (68)
- Structure and expression of B-myc, a new member of the myc gene family (1988) (68)
- Two-colour immunofluorescence studies on EBV-determined antigens. (1971) (67)
- Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomas (2003) (67)
- IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter (2009) (67)
- Fusion of tumour cells with host cells. (1972) (66)
- Assessment of major histocompatibility complex class I interaction with Epstein‐Barr virus and human immunodeficiency virus peptides by elevation of membrane H‐2 and HLA in peptide loading‐deficient cells (1992) (65)
- Intra- and interspecies reactivity of human and mouse natural killer (NK) cells. (1978) (65)
- Use of the Ehrlich ascites tumor of mice for quantitative studies on the growth and biochemistry of neoplastic cells (1950) (65)
- Solubilization of the Epstein-Barr virus-determined nuclear antigen and its characterization as a DNA-binding protein (1977) (64)
- The usefulness and limitations of tumor transplantation in cancer research: a review. (1959) (64)
- Immune and non‐immune control of neoplastic development: Contrasting effects of host and tumor evolution (1980) (64)
- Reversible nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 and hsp70 proteins after exposure to heat shock or cell density congestion. (1995) (64)
- Epstein Barr virus selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigens. (1981) (63)
- Sensitivity of different target cells to the killing action of peripheral lymphocytes stimulated by autologous lymphoblastoid cell lines (1974) (62)
- The nucleic acid content of mouse ascites tumor cells (1950) (62)
- Human cell lines engineered for tetracycline‐regulated expression of tumor suppressor candidate genes from a frequently affected chromosomal region, 3p21 (2002) (62)
- Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene (2004) (62)
- Establishment of Anti‐TNP Antibody‐producing Human Lymphoid Lines by Preselection for Hapten Binding followed by EBV Transformation (1979) (62)
- Cancer, apoptosis, and nonimmune surveillance (2004) (62)
- Antibody reactions to herpesvirus saimiri (HVS)‐induced early and late antigens (EA and LA) in HVS‐infected squirrel, marmoset and owl monkeys (1973) (62)
- Modern Criteria to Establish Human Cancer Etiology (2004) (61)
- Activation of the c-myc oncogene by the immunoglobulin heavy-chain gene enhancer after multiple switch region-mediated chromosome rearrangements in a murine plasmacytoma. (1985) (61)
- Cell phenotype-dependent control of Epstein-Barr virus latent membrane protein 1 gene regulatory sequences. (1993) (61)
- Immune complexes associated with neoplasia: presence of Epstein-Barr virus antigen-antibody complexes in Burkitt's lymphoma. (1974) (61)
- The transformation of a solid transplantable mouse carcinoma into an "ascites tumor". (1951) (61)
- Relationships between complement activation, complement binding, and EBV absorption by human hematopoietic cell lines. (1977) (61)
- Purification and biochemical characterization of the Epstein-Barr virus-determined nuclear antigen and an associated protein with a 53,000-dalton subunit (1980) (61)
- Critical tumor‐suppressor gene regions on chromosome 3P in major human epithelial malignancies: Allelotyping and quantitative real‐time PCR (2002) (61)
- Toward a genetics of cancer resistance (2009) (61)
- Reconstitution of wild-type p53 expression triggers apoptosis in a p53-negative v-myc retrovirus-induced T-cell lymphoma line. (1993) (60)
- Induction of immune responsiveness in a genetically low‐responsive tumor‐host combination by chemical modification of the immunogen (1976) (60)
- Sensitivity to ebv superinfection and IUdR inducibility of hybrid cells formed between a sensitive and a relatively resistant burkitt lymphoma cell line (1973) (60)
- Infection of EBV-genome-negative and -positive human lymphoblastoid cell lines with biologically different preparations of EBV. (1974) (60)
- Relationship between the EBV‐associated membrane antigen on burkitt lymphoma cells and the viral envelope, demonstrated by immunoferritin labelling (1971) (59)
- NotI subtraction and NotI-specific microarrays to detect copy number and methylation changes in whole genomes (2002) (59)
- The analysis of malignancy by cell fusion. VI. Hybrids between different tumour cells. (1974) (59)
- Epstein‐barr virus: Transformation of non‐human primate lymphocytes in vitro (1974) (59)
- Rejectability of virus-induced tumors and nonrejectability of spontaneous tumors: a lesson in contrasts. (1977) (59)
- Relationship between epstein‐barr virus (EBV)‐production and the loss of the ebv receptor/complement receptor complex in a series of sublines derived from the same original burkitt's lymphoma (1978) (58)
- AMPLIFICATION OF THE C‐MYC ONCOGENE IN HUMAN PLASMA‐CELL LEUKEMIA (1985) (58)
- Somatic cell hybrids between human lymphoma lines. III. Surface markers (1977) (58)
- Comparison between growth characteristics of an Epstein--Barr virus (EBV)-genome-negative lymphoma line and its EBV-converted subline in vitro. (1975) (58)
- LACK OF DISTINCTIVE SURFACE ANTIGEN ON CELLS TRANSFORMED BY MURINE SARCOMA VIRUS (1972) (57)
- Immunological aspects of Burkitt's lymphoma. (1971) (57)
- Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan (2012) (57)
- Expression of the RB gene under the control of MuLV-LTR suppresses tumorigenicity of WERI-Rb-27 retinoblastoma cells in immunodefective mice. (1990) (57)
- Direct membrane immunofluorescence reaction of Burkitt's lymphoma cells in culture. (1969) (57)
- Capacity of B‐lymphocytic lines of diverse tumor origin to produce and respond to B‐cell growth factors: A progression model for B‐cell lymphomagenesis (1985) (57)
- Cellular immune defects to Epstein-Barr virus-determined antigens in young males. (1981) (57)
- Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. II. Epstein-Barr virus studies. (1978) (56)
- Chromosome translocations and human cancer. (1985) (56)
- The HLA-dependent expression of testis-organizing H-Y antigen by human male cells (1978) (55)
- aberrant expression of HLA Class‐I antigens in burkitt lymphoma cells (1991) (55)
- Eb‐virus associated serology in malignant disease: antibody levels to viral capsid antigens (vca), membrane antigens (ma) and early antigens (ea) in patients with various neoplastic conditions (1972) (55)
- Multiple phenotypic consequences of the Ig/Myc translocation in B‐cell‐derived tumors (1989) (55)
- Segmental duplications and evolutionary plasticity at tumor chromosome break-prone regions. (2008) (54)
- Is trisomy cause or consequence of murine T cell leukemia development? Studies on Robertsonian translocation mice. (1979) (54)
- Concomitant increase of LMP1 and CD25 (IL‐2‐receptor α) expression induced by IL‐10 in the EBV‐positive NK lines SNK6 and KAI3 (2006) (54)
- Nucleic acid renaturation and restriction endonuclease cleavage analyses show that the DNAs of a transforming and a nontransforming strain of Epstein-Barr virus share approximately 90% of their nucleotide sequences (1976) (54)
- Expression of cyclin D2 and D3 in lymphoid lesions (1999) (54)
- Endogenous TGF‐β contributes to the induction of the EBV lytic cycle in two burkitt lymphoma cell lines (1994) (53)
- Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases. (1994) (53)
- Studies on the effect of X-rays on the biochemistry and cellular composition of ascites tumors. II. Changes in the pattern of glycine-2-14C incorporation during the first two hours after irradiation in vivo. (1954) (53)
- Purification of the Epstein-Barr virus-determined nuclear antigen from Epstein-Barr virus-transformed human lymphoid cell lines (1978) (53)
- Tumor‐bound immunoglobulins. Evidence for the in vivo coating of tumor cells by potentially cytotoxic anti‐tumor antibodies (1976) (52)
- Immunoglobulin synthesis and glucose-6-phosphate dehydrogenase as cell markers in human lymphoblastoid cell lines. (1974) (52)
- Expression of epstein‐barr virus‐encoded proteins and B‐cell markers in fatal infectious mononucleosis (1990) (52)
- An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies. (2003) (52)
- Membrane receptor stripping confirms the association between ebv receptors and complement receptors on the surface of human b lymphoma lines (1977) (52)
- Comparison of the anti‐ebv titer and the ebv‐associated membrane reactive and precipitating antibody levels in the sera of burkitt lymphoma and nasopharyngeal carcinoma patients and controls (1970) (51)
- The effect of storage on the nucleic acid content and virulence of mouse ascites tumor (1950) (51)
- EB viral antigens in burkitt tumor biopsies and early cultures (1970) (51)
- The analysis of malignancy by cell fusion. II. Hybrids between Ehrlich cells and normal diploid cells. (1971) (51)
- Antibody patterns in different human sera against intracellular and membrane-antigen complexes associated with Epstein-Barr virus. (1970) (50)
- B‐lymphocyte subpopulations are equally susceptible to Epstein–Barr virus infection, irrespective of immunoglobulin isotype expression (2003) (50)
- Epstein–Barr virus encoded nuclear protein EBNA-3 binds XAP-2, a protein associated with Hepatitis B virus X antigen (2000) (50)
- Regulation of Transactivation Function of the Aryl Hydrocarbon Receptor by the Epstein-Barr Virus-encoded EBNA-3 Protein* (2006) (50)
- Characterization of a second Epstein‐Barr virus‐determined nuclear antigen associated with the BamHI WYH region of EBV DNA (1985) (49)
- Deoxyribonucleic Acid of Marek's Disease Virus in Virus-Induced Tumors (1973) (49)
- Surface immunoglobulins on Burkitt's lymphoma biopsy cells from 91 patients (1980) (48)
- Isoantigen expression in hybrid mouse cells. (1970) (48)
- Somatic mutation and homozygous deletion of PTEN/MMAC1 gene of 10q23 in renal cell carcinoma. (1999) (48)
- Down regulation of 3p genes, LTF, SLC38A3 and DRR1, upon growth of human chromosome 3–mouse fibrosarcoma hybrids in severe combined immunodeficiency mice (2006) (48)
- Perspectives in studies of human tumor viruses. (2002) (48)
- Histocompatibility changes in tumors. (1958) (48)
- High-level expression of the Epstein-Barr virus EBNA1 protein in CV1 cells and human lymphoid cells using a SV40 late replacement vector. (1986) (48)
- The gene from the short arm of chromosome 3, at D3F15S2, frequently deleted in renal cell carcinoma, encodes acylpeptide hydrolase. (1991) (48)
- SH2D1A and slam protein expression in human lymphocytes and derived cell lines (2000) (48)
- Purification of Epstein-Barr virus DNA polymerase from P3HR-1 cells (1985) (47)
- Chromosome 15 trisomy in spontaneous and carcinogen‐induced murine lymphomas of B‐cell origin (1981) (47)
- Chromosome analysis of two related heteroploid mouse cell lines by quinacrine fluorescence. (1973) (47)
- Lymphoblastoid cell lines and burkitt‐lymphoma‐derivee cell lines differ in the expression of a second epstein‐barr virus encoded nuclear antigen (1986) (47)
- Surveillance against tumors--is it mainly immunological? (2005) (46)
- EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexes (2008) (46)
- Mapping of the c‐myc, pvt‐1 and immunoglobulin kappa genes in relation to the mouse plasmacytoma‐associated variant (6;15) translocation breakpoint. (1985) (46)
- Novel signatures of cancer‐associated fibroblasts (2013) (46)
- Some factors affecting membrane immunofluorescence reactivity of burkitt lymphoma tissue culture cell lines (1969) (46)
- Independence of Moloney virus-induced cell-surface antigen and membrane-associated virion antigens in immunoselected lymphoma sublines (1976) (46)
- Expression of B‐cell‐specific markers in different burkitt lymphoma subgroups (1987) (46)
- bcl-2 inhibits wild-type p53-triggered apoptosis but not G1 cell cycle arrest and transactivation of WAF1 and bax. (1995) (45)
- Proteasome inhibitor induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5. (2001) (45)
- Epstein-Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes (2010) (45)
- In Vitro Cytotoxic Effect of Isoantibody Measured as Isotope Release from Labelled Target Cell DNA (1963) (45)
- Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1. (2006) (45)
- Epstein-Barr virus-encoded nuclear protein EBNA-3 interacts with the epsilon-subunit of the T-complex protein 1 chaperonin complex. (1999) (45)
- The epstein‐barr‐virus‐encoded membrane protein LMP but not the nuclear antigen EBNA‐1 induces rejection of transfected murine mammary carcinoma cells (1991) (45)
- RNA polymerase III-transcribed EBER 1 and 2 transcription units are expressed and hypomethylated in the major Epstein-Barr virus-carrying cell types. (1992) (45)
- The Epstein-Barr virus encoded membrane protein (LMP) induces phenotypic changes in epithelial cells (1992) (44)
- HYAL1 and HYAL2 Inhibit Tumour Growth In Vivo but Not In Vitro (2008) (44)
- NK sensitivity and lung clearance of MHC‐class‐I‐deficient cells within a heterogeneous fibrosarcoma (1989) (44)
- In vitro Cytotoxic Effect of Lymphoid Cells from Mice Immunized with Allogeneic Tissue (1964) (44)
- The role of science. (1988) (44)
- Non‐random chromosomal changes involving chromosomes 6 and 7 in spontaneous rat immunocytomas (1982) (44)
- Loss of heterozygosity in tumor cells requires re‐evaluation: the data are biased by the size‐dependent differential sensitivity of allele detection (1999) (44)
- Tumor cell dormancy: implications for the biology and treatment of breast cancer (2008) (44)
- Expression profile of nuclear receptors upon Epstein -- Barr virus induced B cell transformation. (2009) (44)
- Studies of burkitt lymphoma cells. I. Establishment of a cell line (B35M) and its characteristics (1967) (43)
- Circulating Antigen-Antibody Complex Associated With Epstein-Barr Virus in Recurrent Burkitt's Lymphoma (1973) (43)
- Epstein-Barr virus (EBV)-induced change in the saturation sensitivity and serum dependence of established, EBV-negative lymphoma lines in vitro. (1976) (42)
- Resting B-cells, EBV-infected B-blasts and established lymphoblastoid cell lines differ in their Rb, p53 and EBNA-5 expression patterns. (1995) (42)
- Antibody-induced redistribution of normal and tumor associated surface antigens. (1974) (42)
- Epstein‐barr virus (EBV)‐associated antibody patterns in malignant lymphoma and leukemia. II. Chronic lymphocytic leukemia and lymphocytic lymphoma (1971) (42)
- Coupled transcription of Epstein-Barr virus latent membrane protein (LMP)-1 and LMP-2B genes in nasopharyngeal carcinomas. (1995) (42)
- Differences in the immunogenicity of latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus genomes derived from LMP1-positive and -negative nasopharyngeal carcinoma. (2000) (42)
- The proapoptotic function of SAP provides a clue to the clinical picture of X-linked lymphoproliferative disease (2009) (42)
- Further studies on the relationship between large glycoprotein molecules and allotransplantability in the TA3 tumor of the mouse: studies on segregating TA3-HA hybrids. (1978) (42)
- Relationship between the Epstein‐Barr virus genome and nasopharyngeal carcinoma in Caucasian patients (1979) (42)
- Paired Epstein‐Barr virus (EBV)‐negative and EBV‐converted Burkitt lymphoma lines: Stimulatory capacity in allogeneic mixed lymphocyte cultures (1987) (41)
- Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. I. Immunofluorescence. (1974) (41)
- Cross-reactivity between the EBNA-1 p107 peptide, collagen, and keratin: implications for the pathogenesis of rheumatoid arthritis. (1990) (41)
- EBV‐encoded EBNA‐5 associates with P14ARF in extranucleolar inclusions and prolongs the survival of P14ARF‐expressing cells (2003) (41)
- Cellular reactions against Burkitt lymphoma cells. III. Effector cell activity of leukocytes stimulated in vitro with autochthonous cultured lymphoma cells (1972) (41)
- Elevated antibody titers to Epstein-Barr virus and low natural killer cell activity in patients with Chediak-Higashi syndrome. (1983) (41)
- A weakly tumorigenic phenotype with high mhc class‐i expression is associated with high metastatic potential after surgical removal of the primary murine fibrosarcoma (1990) (41)
- Foulds' dangerous idea revisited: the multistep development of tumors 40 years later. (1996) (41)
- T cell leukemia I oncogene expression depends on the presence of Epstein–Barr virus in the virus- carrying Burkitt lymphoma lines (2003) (41)
- Studies of sublines selected for loss of HLA expression from an EBV-transformed lymphoblastoid cell line. Changes in sensitivity to cytotoxic T cells activated by allostimulation and natural killer cells activated by IFN or IL-2. (1989) (41)
- Somatic cell hybrids between human lymphoma lines. II. Spontaneous and induced patterns of the Epstein‐Barr virus (EBV) cycle (1976) (40)
- Chromosome analyses of lymphoid cell lines derived from patients with chronic lymphocytic leukemia (1980) (40)
- RELATION BETWEEN EPSTEIN-BARR VIRAL AND CELL MEMBRANE IMMUNOFLUORESCENCE IN BURKITT TUMOR CELLS (1969) (40)
- Triplication of one chromosome no. 15 with an altered C‐myc containing ecori fragment and elimination of the normal homologue in a T‐cell lymphoma line of akr origin (TIKAUT) (1984) (40)
- Are methylcholanthrene‐induced sarcoma‐associated, rejection‐inducing (TSTA) antigens, modified forms of H‐2 or linked determinants? (1975) (40)
- EBV‐expressing AGS gastric carcinoma cell sublines present increased motility and invasiveness (2002) (39)
- Detection of a nuclear, EBNA‐type antigen in apparently EBNA‐negative Herpesvirus papio (HVP)‐transformed lymphoid lines by the acid‐fixed nuclear binding technique (1977) (39)
- Cell-surface immunoglobulin and insulin receptor expression in an EBV-negative lymphoma cell line and its EBV-converted sublines. (1981) (39)
- Afferent and efferent cellular interactions in natural resistance directed against MHC class I deficient tumor grafts. (1988) (39)
- Genetic Studies of the Relationship of Tumour–Host Cells: Detection of an Allelic Difference at a Single Gene Locus in a Small Fraction of a Large Tumour-Cell Population (1956) (39)
- Decreased decorin expression in the tumor microenvironment (2014) (39)
- TWO KINDS OF ANTIGEN SUPPRESSION IN TUMOR CELLS REVEALED BY CELL FUSION (1972) (39)
- Classification of lymphocytes in nasopharyngeal carcinoma (NPC) biopsies. (1975) (39)
- Epstein-Barr virus genome studies in Burkitt's and non-Burkitt's lymphomas in Uganda. (1977) (38)
- Antibodies against cytomegalovirus-induced early antigens (CMV-EA) in immunosuppressed renal-allograft recipients. (1977) (38)
- Establishment of a lymphoid cell line from leukemic cells of a patient with chronic lymphocytic leukemia (1980) (38)
- Expression of the bla antigen, defined by the monoclonal 38.13 antibody, on burkitt lymphoma lines, lymphoblastoid cell lines, their hybrids and other b‐cell lymphomas and leukemias (1983) (38)
- The transcriptional map of the common eliminated region 1 (C3CER1) in 3p21.3 (2002) (38)
- SPR-based immunocapture approach to creating an interfacial sensing architecture: mapping of the MRS18-2 binding site on retinoblastoma protein (2006) (38)
- Expression of the Epstein‐Barr virus (EBV)‐encoded membrane antigen (LMP) increases the stimulatory capacity of EBV‐negative B lymphoma lines in allogeneic mixed lymphocyte cultures (1990) (38)
- Expression of a second Epstein-Barr virus-determined nuclear antigen in mouse cells after gene transfer with a cloned fragment of the viral genome. (1985) (38)
- Identification of Novel Epigenetic Markers of Prostate Cancer by NotI-Microarray Analysis (2015) (38)
- Soluble factors produced by activated CD4+ T cells modulate EBV latency (2012) (38)
- Nonrandom chromosomal changes in thy-1-positive and thy-1-negative lymphomas induced by 7,12-dimethylbenzanthracene in SJL mice. (1980) (38)
- Subcellular localization of the retinoblastoma protein. (1991) (37)
- PRIMA-1MET induces nucleolar accumulation of mutant p53 and PML nuclear body-associated proteins (2007) (37)
- Hemizygous interstitial deletion of chromosome 15 (band D) in three translocation-negative murine plasmacytomas. (1984) (37)
- Epstein‐Barr virus nuclear antigen‐1 and Myc cooperate in lymphomagenesis (2003) (37)
- Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection (1990) (37)
- Lack of correlation between EBV serology and presence of EBV in the Hodgkin and Reed‐Sternberg cells of patients with Hodgkin's disease (1997) (37)
- EB virus‐associated antibodies in caucasian patients with carcinoma OE the nasopharynx and in long‐term survivors after treatment (1974) (37)
- High Mutability of the Tumor Suppressor Genes RASSF1 and RBSP3 (CTDSPL) in Cancer (2009) (37)
- Cytogenetic studies on IgA/lambda-producing murine plasmacytomas: Regular occurrence of a T(12;15) translocation (1980) (36)
- Why do we not all die of cancer at an early age? (2007) (36)
- Endogenous TGF-beta contributes to the induction of the EBV lytic cycle in two Burkitt lymphoma cell lines. (1994) (36)
- Difference in antibody induced redistribution of membrane IgM in EBV geonome free and EBV positive human lymphoid cells. (1976) (36)
- Epstein‐barr virus‐specific serodiagnostic tests in carcinomas of the head and neck (1983) (36)
- Reversion of tumorigenicity and decreased agarose clonability after EBV conversion of an igh/myc translocation‐carrying be line (1989) (36)
- Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum‐mediated lysis (1992) (36)
- In vitro EBV‐infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA‐1, while CD40 ligand and IL‐4 induce LMP‐1 but not EBNA‐2 (2005) (36)
- Tumor-host cell hybrids in radiochimeras. (1974) (36)
- Rearrangement of c‐myc, pim‐1 and Mlvi‐1 and trisomy of chromosome 15 in MCF‐ and moloney‐MuLV‐induced murine T‐cell leukemias (1986) (36)
- Relationship between amount of Epstein–Barr virus-determined nuclear antigen per cell and number of EBV–DNA copies per cell (1977) (36)
- Further studies on the membrane immunofluorescence reaction of Burkitt lymphoma cells (1967) (35)
- Effect of metabolic inhibitors on membrane immunofluorescence reactivity of established burkitt lymphoma cell lines (1970) (35)
- 6;7 chromosomal translocation in spontaneously arising rat immunocytomas: evidence for c-myc breakpoint clustering and correlation between isotypic expression and the c-myc target (1988) (35)
- SH2D1A expression in Burkitt lymphoma cells is restricted to EBV positive group I lines and is downregulated in parallel with immunoblastic transformation (2002) (35)
- Functional and molecular characterization of B cell‐responsive Vδ1+ γδ T cells (1994) (35)
- Immunological Tolerance of Neonatally Infected Mice to the Moloney Leukaemia Virus (1966) (34)
- Second malignant clone underlying a Burkitt-tumor exacerbation. (1972) (34)
- Immunological control of human lymphoma: discussion. (1976) (34)
- Selective acceptance of MHC class I-deficient tumor grafts in the brain (1988) (34)
- EBV-transformation of surface IgA-positive human lymphocytes. (1980) (34)
- Antigen processing and presentation by EBV‐carrying cell lines: Cell‐phenotype dependence and influence of the EBV‐encoded LMP1 (1993) (34)
- Production of infectious Epstein–Barr virus in mouse lymphocytes (1981) (33)
- Malignancy of Somatic Cell Hybrids (reply) (1969) (33)
- SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines. (2000) (33)
- Attempts to induce interferon production by IdUrd induction and EBV superinfection in human lymphoma lines and their hybrids. (1980) (33)
- Antinuclear reactivity of sera in patients with leukemia and other neoplastic diseases. (1975) (33)
- UV light-induced immunoglobulin heavy-chain class switch in a human lymphoblastoid cell line (1983) (33)
- Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines. (1996) (33)
- Further studies on isoantigenic variation in mouse carcinomas and sarcomas. (1960) (33)
- Induction of the EBV cycle in B‐lymphocyte‐derived lines is accompanied by increased natural killer (NK) sensitivity and the expression of EBV‐related antigen(s) detected by the ADCC reaction (1980) (33)
- Microcell‐mediated chromosome transfer provides evidence that polysomy promotes structural instability in tumor cell chromosomes through asynchronous replication and breakage within late‐replicating regions (2004) (33)
- Differences in the ConA-induced redistribution and agglutination patterns of EBV genome-free and EBV-carrying human lymphoma lines. (1977) (33)
- Demonstration of host resistance against sarcomas induced by implantation of cellophane films in isologous (syngeneic) recipients. (1963) (33)
- Separation of the moloney leukemia virus‐determined cell surface antigen (MCSA) from known virion proteins associated with the cell membrane (1977) (33)
- HHV-8 encoded LANA-1 alters the higher organization of the cell nucleus (2007) (32)
- Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains. (1983) (32)
- High resolution banding analysis of the involvement of strain BALB/c- and AKR-derived chromosomes No. 15 in plasmacytoma-specific translocations (1984) (32)
- Mechanisms of allele‐selective down‐regulation of HLA class I in Burkitt's lymphoma (1995) (32)
- Allele-specific down-regulation of MHC class I antigens in Burkitt lymphoma lines. (1989) (32)
- Simultaneous detection of two independent antigens by double staining with two mouse monoclonal antibodies. (1998) (32)
- The LZTFL1 gene is a part of a transcriptional map covering 250 kb within the common eliminated region 1 (C3CER1) in 3p21.3. (2001) (32)
- Segregation of the EBV‐determined nuclear antigen (EBNA) in somatic cell hybrids derived from the fusion of a mouse fibroblast and a human burkitt lymphoma line (1974) (32)
- Amplification of c-myc and pvt-1 homologous sequences in acute nonlymphatic leukemia. (1988) (32)
- Activated T lymphocytes in infiltrates and draining lymph nodes of nasopharyngeal carcinoma (1980) (32)
- Differential expression of hla antigen of HLA anigens on human B‐cell lines of normal and malignant origin: A consequence of immune surveillance or a phenotypic vestige of the progenitor cells? (1988) (32)
- Immunization of mice with syngeneic Moloney lymphoma cells induces separate antibodies against virion envelope glycoprotein and virus- induced cell surface antigens (1977) (32)
- BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations. (2003) (31)
- Epigenetics: Surveillance team against cancer (2005) (31)
- Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. I. Complement receptor distribution and complement binding by separated lymphocyte subpopulations. (1978) (31)
- Nuclear colocalization of c-myc protein and hsp70 in cells transfected with human wild-type and mutant c-myc genes. (1992) (31)
- T Cells Modulate Epstein-Barr Virus Latency Phenotypes during Infection of Humanized Mice (2014) (31)
- Changes in chemokines and chemokine receptor expression on tonsillar B cells upon Epstein–Barr virus infection (2009) (31)
- Effect of different Epstein-Barr virus-determined antigens (EBNA, EA, and VCA) on the leukocyte migration of healthy donors and patients with infectious mononucleosis and certain immunodeficiencies. (1982) (31)
- hUNC93B1: a novel human gene representing a new gene family and encoding an unc-93-like protein. (2002) (31)
- Evolutionary aspects of cancer resistance. (2014) (31)
- Down‐regulation of the EBV‐encoded membrane protein (LMP) in burkitt lymphomas (1987) (30)
- Oncogenes and tumor suppressor genes. (1988) (30)
- Similar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumor growth in severe combined immunodeficient (SCID) mice. (2001) (30)
- Further studies on the differences in serum dependence in EBV negative lymphoma lines and their in vitro EBV converted, virus-genome carrying sublines. (1977) (30)
- Antibody response and leukemia development in mice inoculated neonatally with the Moloney virus. (1965) (30)
- HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1. (1995) (30)
- CD40 ligation downregulates EBNA‐2 and LMP‐1 expression in EBV‐transformed lymphoblastoid cell lines (2002) (30)
- Murine Cytotoxic T Lymphocytes Recognize an Epitope in an EBNA-1 Fragment, but Fail to Lyse EBNA-1–expressing Mouse Cells (1998) (29)
- A 1-Mb PAC contig spanning the common eliminated region 1 (CER1) in microcell hybrid-derived SCID tumors. (1999) (29)
- Epstein-Barr virus-encoded EBNA-5 binds to Epstein-Barr virus-induced Fte1/S3a protein. (2004) (29)
- Epstein-Barr virus encoded nuclear protein EBNA-3 binds a novel human uridine kinase/uracil phosphoribosyltransferase (2002) (29)
- SOME CHARACTERISTICS OF 19S AND 7S MOUSE ISOANTIBODIES IN VIVO AND IN VITRO (1967) (29)
- RhoA knockout fibroblasts lose tumor-inhibitory capacity in vitro and promote tumor growth in vivo (2017) (29)
- Human leukemia-associated anti-nuclear reactivity. (1974) (29)
- The construction of a yeast artificial chromosome (YAC) contig in the vicinity of the Usher syndrome type IIa (USH2A) gene in 1q41. (1996) (29)
- Lymphoma in Cardiac Transplant Recipients Associated with Cyclosporin A, Prednisone and Anti-Thymocyte Globulin (ATG) (1984) (29)
- Expression of the epstein‐barr virus (EBV)‐encoded membrane protein LMP1 impairs the In vitro growth, clonability and tumorigenicity of an EBV‐negative burkitt lymphoma line (1992) (29)
- Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. II. Immunoelectron microscopy. (1974) (29)
- Burkitt lymphoma--a stalking horse for cancer research? (2009) (29)
- Identification of human chromosomes in a mouse-human hybrid by fluorescence techniques. (1971) (29)
- Epstein-Barr virus (EBV) antigens processed and presented by B cells, B blasts, and macrophages trigger T-cell-mediated inhibition of EBV-induced B-cell transformation (1990) (29)
- Epstein‐barr virus (EBV)‐induced lymphoproliferative disease in cotton‐topped marmosets (1983) (28)
- Surface antigens and release of virus in hybrid cells produced by the fusion of A9 fibroblasts with Moloney Lymphoma cells. (1971) (28)
- Expression of SH2D1A in five classical Hodgkin's disease‐derived cell lines (2003) (28)
- Burkitt lymphoma cells in expressing EBNA-1 infected with Epstein-Barr virus resembles A subpopulation of normal B cells latently (1995) (28)
- Immunologic factors involved in the growth of primary tumors in human or animal hosts (1969) (28)
- p14ARF induces the relocation of HDM2 and p53 to extranucleolar sites that are targeted by PML bodies and proteasomes (2003) (28)
- Epstein-Barr Virus-Associated Membrane-Reactive Antibodies During Long Term Survival After Burkitt's Lymphoma (1974) (28)
- Attempts to detect virus-specific DNA sequences in human tumors (1975) (28)
- Interferon γ is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells (2017) (28)
- The gene encoding CD23 leukocyte antigen (FCE2) is located on human chromosome 19 (1990) (28)
- Phorbol 12,13-dibutyrate (P(Bu)2)-treated human blood mononuclear cells bind to each other. (1983) (28)
- Epstein-Barr Virus Infection to Epstein-Barr Virus-Negative Nasopharyngeal Carcinoma Cell Line TW03 Enhances Its Tumorigenicity (2000) (28)
- Epstein–Barr virus infection negatively impacts the CXCR4‐dependent migration of tonsillar B cells (2006) (28)
- Detection of Epstein-Barr virus (EBV) DNA sequences using in situ hybridization. (1978) (28)
- Selection of tumor-host cell hybrids from polyoma virus- and methylcholanthrene-induced sarcomas. (1973) (27)
- CD28 is not required for rejection of unmanipulated syngeneic and autologous tumors (1997) (27)
- Hybrid cells derived from fusion of TA3-Ha ascites carcinoma with normal fibroblasts. 1. Malignancy, karyotype, and formation of isoantigenic variants. (1973) (27)
- Non‐random duplication of chromosome 15 in murine T‐cell leukemias: Further studies on translocation heterozygotes (1980) (27)
- Increased immunogenicity of low‐antigenic rat tumors after superinfection with endogenous murine C‐type virus in nude mice (1978) (27)
- Establishment of specific antibody producing human lines by antigen preselection and EBV-transformation. (1978) (27)
- The architecture of fibroblast monolayers of different origin differentially influences tumor cell growth (2012) (27)
- Overall changes in chromatin sensitivity to DNase I during differentiation. (1987) (27)
- Mouse Antibody Production Test for the Assay of the Moloney Virus (1964) (26)
- PSK and Trx80 inhibit B-cell growth in EBV-infected cord blood mononuclear cells through T cells activated by the monocyte products IL-15 and IL-12. (2005) (26)
- Conversion of the lymphoma line “BJAB” by Epstein‐Barr virus into phenotypically altered sublines is accompanied by increased C‐myc mRNA levels (1987) (26)
- Non‐random duplication of chromosome 15 in murine T‐cell leukemias induced in mice heterozygous for translocation 1(14:15)6 (1979) (26)
- Serologically detectable specific and cross‐reactive antigens on the membrane of a polyoma virus‐induced murine tumor (1976) (26)
- Cytogenetic studies on abelson‐virus‐induced mouse leukemias (1980) (26)
- Restoration of H‐2b expression and processing of endogenous antigens in the MHC class I pathway by fusion of a lymphoma mutant to L cells of the H‐2k haplotype (1990) (26)
- Epstein‐Barr virus‐encoded EBNA‐5 forms trimolecular protein complexes with MDM2 and p53 and inhibits the transactivating function of p53 (2011) (26)
- Effect of the ebna‐2 gene on the surface antigen phenotype of transfected ebv‐negative B‐lymphoma lines (1990) (26)
- Wild-type p53 activates SAP expression in lymphoid cells (2004) (26)
- Human chromosomes in 18 man-mouse somatic hybrid cell lines analysed by quinacrine fluorescence. (1973) (26)
- Nuclear DNA-binding proteins determined by the Epstein-Barr virus-related simian lymphotropic herpesviruses H. gorilla, H. pan, H. pongo and H. papio. (1987) (26)
- Intranuclear redistribution of SV40T, p53, and PML in a conditionally SV40T-immortalized cell line. (1996) (25)
- Permanent modification (mutation?) of a histocompatibility gene in a heterozygous tumor. (1957) (25)
- Stimulation of peripheral human lymphocytes by autologous EBV genome-carrying lymphoblastoid cell lines. (1978) (25)
- THE INFLUENCE OF THE PARTNER CELL ON THE PRODUCTION OF L VIRUS AND THE EXPRESSION OF VIRAL SURFACE ANTIGEN IN HYBRID CELLS (1973) (25)
- A 3q+ marker chromosome in EBV‐carrying nasopharyngeal carcinomas (1983) (24)
- Histopathologic studies of peritoneal implantation and lung metastasis at different stages of the gradual transformation of the MCIM mouse sarcoma into ascites form. (1957) (24)
- Genes that can antagonize tumor development (1993) (24)
- Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and incompatible tumor cells. (1972) (24)
- B‐CLL cells with unusual properties (1997) (24)
- Thirteen new mammary tumor cell lines from different mouse strains. (1980) (24)
- Blastogenic response of purified human T-lymphocyte populations to Epstein-Barr virus (EBV). (1977) (24)
- Experiences with a frozen tumor bank. (1957) (24)
- 12-O- tetradecanoylphorbol- 13 acetate (TPA) treatment elevates the natural killer (NK) sensitivity of certain human lymphoid lines. (1981) (24)
- Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells. (2012) (23)
- The interferon-α responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma (2007) (23)
- Establishment of specific antibody producing human lines by antigen preselection and Epstein-Barr virus (EBV)-transformation. (1979) (23)
- Do human renal cell carcinomas arise by a double-loss mechanism? (1988) (23)
- Infrequent MDM2 gene amplification and absence of gross WAF1 gene alterations in nasopharyngeal carcinoma. (1995) (23)
- An old acquaintance resurfaces in human mesothelioma (1997) (23)
- Epstein-barr virus can infect B-chronic lymphocytic leukemia cells but it does not orchestrate the cell cycle regulatory proteins. (2001) (23)
- Is conversion of solid into more anoxic ascites tumors associated with p53 inactivation? (1998) (23)
- Multiple chromosomal rearrangements in a spontaneously arising t(6;7) rat immunocytoma juxtapose c-myc and immunoglobulin heavy chain sequences. (1986) (23)
- Further studies on the relationship between allotransplantability and the presence of the cell surface glycoprotein epiglycanin in the TA3-MM mouse mammary carcinoma ascites cell. (1982) (23)
- SUBCELLULAR LOCALIZATION OF MURINE HISTOCOMPATIBILITY ANTIGENS IN TUMOR CELLS: Localization of H-2 Antigens (1973) (23)
- Cell-mediated immune reactions in three patients with malignant lymphoproliferative diseases in remission and abnormally high Epstein-Barr virus antibody titers. (1981) (23)
- Immunofluorescence and anti‐complement immunofluorescence absorption tests for quantitation of epstein‐barr virus‐associated antigens (1975) (23)
- Gamma‐interferon (IFN‐γ) produced during effector and target interactions renders target cells less susceptible to NK‐cell‐mediated lysis (1983) (22)
- Advances in cancer research vol. 50 (1988) (22)
- Development of a spectrum of ascites tumors (1951) (22)
- The amino-terminal phosphorylation sites of C-MYC are frequently mutated in Burkitt's lymphoma lines but not in mouse plasmacytomas and rat immunocytomas. (1995) (22)
- Reintroduction of a normal retinoblastoma gene into retinoblastoma and osteosarcoma cells inhibits the replication associated function of SV40 large T antigen. (1991) (22)
- Chromosomal heterogeneity in the RAG and MSWBS mouse tumor cell lines. (1974) (22)
- Genetic variation in antibody response and natural killer cell activity against a Moloney virus‐induced lymphoma (YAC) (1977) (22)
- Cytogenetic studies on the mechanism of formation of isoantigenic variants in somatic cell hybrids. I. Banding analyses of isoantigenic variant sublines derived from the fusion of TA3Ha carcinoma with MSWBS sarcoma cells. (1974) (22)
- Host cell-dependent regulation of growth transformation-associated Epstein-Barr virus antigens in somatic cell hybrids (1989) (22)
- Cellular reactions against Burkitt lymphoma cells. I. Colony inhibition with effector cells from patients with Burkitt's lymphoma (1972) (22)
- Superinfection with Epstein-Barr virus of human lymphoid cell lines of different origin. (1973) (22)
- Herpesvirus saimiri antigens and virus recovery from cultured cells and antibody levels and virus isolations from squirrel monkeys. (1973) (22)
- A long-term memory obtained by genetic immunization results in full protection from a mammary adenocarcinoma expressing an EBV gene. (1999) (22)
- Epstein-Barr virus infection and mitogen stimulation of normal B cells induces wild-type p53 without subsequent growth arrest or apoptosis. (1999) (22)
- Human B cell line deficient in the expression of B cell‐specific glycoproteins (GP 27,35) (1977) (22)
- Establishment of a human lymphoblastoid cell line with specific antibody production against group A streptococcal carbohydrate. (1979) (22)
- Increase in antibody titer against the EBV‐associated membrane antigen complex in Burkitt's lymphoma and nasopharyngeal carcinoma after local irradiation (1970) (22)
- Expression of polyoma-induced transplantation antigen in hybrid cell lines. (1972) (21)
- Differential survival of solid tumor cells after inoculation into established ascites tumors. (1954) (21)
- Early DNA-binding polypeptides of Epstein-Barr virus. (1981) (21)
- p53 contributes to T cell homeostasis through the induction of pro-apoptotic SAP (2012) (21)
- Direct outgrowth of in vivo epstein‐barr virus (EBV)‐infected chronic lymphocytic leukemia (CLL) cells into permanent lines (1988) (21)
- Consistent downregulation of human lactoferrin gene, in the common eliminated region 1 on 3p21.3, following tumor growth in severe combined immunodeficient (SCID) mice. (2003) (21)
- Correlation between lymphocyte-mediated auto-tumor reactivities and clinical course (1983) (21)
- The selection of somatic cell hybrids between human lymphoma cell lines (1976) (21)
- Immunization against the polyoma virus-induced tumor-specific transplantation antigen by early region mutants of the virus (1982) (21)
- Epstein-Barr virus (EBV)-associated antibody patterns in relation to the deficiency of cell-mediated immunity in patients with Hodgkin's disease. (1975) (21)
- Immunological factors affecting tumour growth. (1970) (21)
- Foreign-cell contamination in Burkitt tumours. (1971) (21)
- Epstein‐Barr virus genomes are found predominantly in IgA‐positive B cells in the blood of healthy carriers (1999) (21)
- Tumorigenicity of Epstein‐barr virus (EBV)‐transformed lymphoid line cells in autologous squirrel monkeys (1976) (20)
- Fatal infectious mononucleosis. (1980) (20)
- Workshop in human tumor immunology. (1972) (20)
- The viability and the average desoxypentosenucleic acid content of micronuclei-containing cells produced by colchicine treatment in the Ehrlich ascites tumor. (1952) (20)
- Immune surveillance--a powerful mechanism with a limited range. (1976) (20)
- The genetic control of natural killer cell activity and its association with in vivo resistance against a moloney lymphoma isograft (1976) (20)
- The Affinity of Soluble Immune Complexes for Concanavalin A (1978) (20)
- Translocations involving Ig-locus-carrying chromosomes: a model for genetic transposition in carcinogenesis. (1982) (20)
- Somatic cell hybrids between human lymphoma lines. IV. Establishment and characterization of a p3HR‐1/daudi hybrid (1978) (19)
- Separation of Ehrlich Ascites Tumour Cells from other Cellular Elements (1955) (19)
- A new variant 15; 16 translocation in mouse plasmacytoma leads to the juxtaposition of c-myc and immunoglobulin lambda. (1991) (19)
- Persistence of Epstein‐barr viral nuclear antigen (EBNA) in cells entering the eb viral cycle (1976) (19)
- Visualization of Alternative Epstein-Barr Virus Expression Programs by Fluorescent In Situ Hybridization at the Cell Level (1999) (19)
- A yeast artificial chromosome (YAC) contig encompassing the critical region of the X-linked lymphoproliferative disease (XLP) locus. (1997) (19)
- Induction of the feline oncornavirus associated cell membrane antigen in human cells. (1972) (19)
- Synthesis of thymidine kinase (TK) in Epstein-Barr virus-superinfected Raji TK-negative cells. (1981) (19)
- Moloney leukemia virus-induced cell surface antigen: detection and characterization in sodium dodecyl sulfate gels. (1977) (19)
- Latency Type-Dependent Modulation of Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Expression by Type I Interferons in B Cells (2012) (19)
- C3-activating proteases on human lymphoblastoid cells superinfected with Epstein-Barr Virus. (1980) (19)
- Induction of HLA expression in Daudi cells after cell fusion (1977) (19)
- Correlation between lymphocyte-mediated auto-tumor reactivities and the clinical course (1983) (19)
- MRPS18–2 protein immortalizes primary rat embryonic fibroblasts and endows them with stem cell-like properties (2009) (19)
- STUDIES ON THE MECHANISM OF ISOANTIGENIC VARIANT FORMATION IN HETEROZYGOUS MOUSE TUMORS. III. BEHAVIOR OF H-2 ANTIGENS D AND K WHEN LOCATED IN THE TRANS POSITION. (1964) (18)
- Immune and non-immune control of neoplastic development: contrasting effects of host and tumor evolution. (1980) (18)
- B cell activation by the nontransforming P3HR‐1 substrain of the Epstein‐Barr virus (EBV) (1986) (18)
- The Epstein‐Barr virus determined nuclear antigen is composed of at least three different anitgens (1986) (18)
- Different Mechanisms of Regulation of the Warburg Effect in Lymphoblastoid and Burkitt Lymphoma Cells (2015) (18)
- Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody. (1984) (18)
- Comparative in vitro sensitivity of two methylcholanthrene‐induced murine sarcoma lines to humoral and cellular immune cytotoxicity (1975) (18)
- Comparative human/murine sequence analysis of the common eliminated region 1 from human 3p21.3 (2002) (18)
- Effect of local radiotherapy on the antibody levels against ebv‐induced early and capsid antigens (ea and vca) in patients with certain malignant tumours (1972) (18)
- Leukotriene B4 activates T cells that inhibit B-cell proliferation in EBV-infected cord blood-derived mononuclear cell cultures. (2008) (18)
- Analysis of restriction endonuclease fragments of intracellular Epstein-Barr virus DNA and isoenzymes indicate a common origin of the Raji, NC-37, and F-265 human lymphoid cell lines. (1981) (18)
- Inhibition of DNA Synthesis of Target Cells in vitro by Sensitized Lymphocytes (1967) (18)
- Conversion of Solid into Ascites Tumours (1953) (18)
- A novel gene containing LIM domains (LIMD1) is located within the common eliminated region 1 (C3CER1) in 3p21.3 (1999) (18)
- Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines. (1995) (17)
- Studies on the polyoma‐virus‐induced tumor‐specific transplantation antigen (TSTA) ‐ does middle or large T‐antigen play a role? (1984) (17)
- Intranuclear distribution of Epstein-Barr virus-encoded nuclear antigens EBNA-1, -2, -3 and -5. (1991) (17)
- Parallel existence of Epstein-Barr virus (EBV) positive and negative cells in a sporadic case of Burkitt lymphoma. (1995) (17)
- Array-CGH and multipoint FISH to decode complex chromosomal rearrangements (2006) (17)
- The interferon-alpha responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma. (2007) (17)
- Immunoglobulin gene associated chromosomal translocations in B-cell derived tumors. (1999) (17)
- A solid-phase radioimmunoassay for Epstein-Barr virus-associated membrane antigen prepared from B95-8 cell culture supernatants. (1977) (17)
- The changing faces of EBV research. (1984) (17)
- Type I interferons directly down-regulate BCL-6 in primary and transformed germinal center B cells: differential regulation in B cell lines derived from endemic or sporadic Burkitt's lymphoma. (2012) (17)
- Evolutionarily plastic regions at human 3p21.3 coincide with tumor breakpoints identified by the "elimination test". (2005) (17)
- Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients. (1997) (17)
- Migration-inhibiting effect of sera from patients with Burkitt's lymphoma. (1973) (17)
- Rearrangements of the telomeric region of mouse chromosome 11 in Pre-B ABL/MYC cells revealed by mBANDing, spectral karyotyping, and fluorescence in-situ hybridization with a subtelomeric probe (2005) (17)
- Induction of tumor cell rejection in the low responsive YAC-lymphoma strain A host combination by immunization with somatic cell hybrids. (1979) (17)
- Chromosome localization and expression pattern of Lmyc and Bmyc in murine embryonal carcinoma cells. (1988) (17)
- Blocking of direct membrane immunofluorescence in titration of membrane-reactive antibodies associated with Epstein-Barr virus. (1971) (17)
- Radioiodine-labeled antibody test for the detection of membrane antigens associated with Epstein-Barr virus. (1972) (16)
- Gene localization on sorted chromosomes: definitive evidence on the relative positioning of genes participating in the mouse plasmacytoma-associated typical translocation. (1985) (16)
- Effect of B‐lymphocyte‐ and NPC‐derived EBV‐1 gene expression on in vitro growth and differentiation of human epithelial cells (1994) (16)
- Relationship between the amounts of EBV‐DNA and ebna per cell, clonability and tumorigenicity in two EBV‐negative lymphoma lines and their EBV‐converted sublines (1983) (16)
- Double immunoglobulin production in cloned somatic cell hybrids between two human lymphoid cell lines (1977) (16)
- Comparative analysis of the Epstein-Barr virus encoded nuclear proteins of EBNA-3 family (2009) (16)
- Epstein‐Barr virus (EBV) receptor implantation onto human B lymphocytes changes immunoglobulin secretion patterns induced by EBV infection (1982) (16)
- Combined treatment with interferon (IFN)-γ and tumor necrosis factor (TNF)-α up-regulates the expression of HLA class I determinants in Burkitt lymphoma lines (1988) (16)
- To the genesis of Burkitt lymphoma: regulation of apoptosis by EBNA-1 and SAP may determine the fate of Ig-myc translocation carrying B lymphocytes. (2009) (16)
- The MEC1 and MEC2 Lines Represent Two CLL Subclones in Different Stages of Progression towards Prolymphocytic Leukemia (2014) (16)
- Coincidence of synteny breakpoints with malignancy-related deletions on human chromosome 3 (2003) (16)
- Intranuclear localization of the transcription coadaptor CBP/p300 and the transcription factor RBP-Jk in relation to EBNA-2 and -5 in B lymphocytes. (2001) (16)
- Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice. (1992) (16)
- Upregulation of the truncated basic hair keratin 1(hHb1‐ΔN) in carcinoma cells by Epstein‐Barr virus (EBV) (2003) (16)
- Nucleic Acid Content of Tumour Cells (1950) (16)
- Stem cell gene expression in MRPS18-2-immortalized rat embryonic fibroblasts (2012) (16)
- Constitutive activation of oncogenes by chromosomal translocations in B-cell derived tumors. (1986) (16)
- Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones. (1986) (16)
- Detection of Epstein‐Barr virus (EBV)‐associated nuclear antigen in human lymphoblastoid cell lines by means of an 125I‐IgG‐binding assay (1974) (16)
- Mouse natural killer (NK) cell activity against human cell lines is not influenced by superinfection of the target cell with xenotropic murine c‐type virus (1978) (15)
- The accelerating role of abelson murine leukemia virus in murine plasmacytoma development: in vitro infection of spleen cells generates donor‐type tumors after transfer to pristane‐treated BALB/c mice (1989) (15)
- Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors. (2000) (15)
- Mouse and rat B-myc share amino acid sequence homology with the c-myc transcriptional activator domain and contain a B-myc specific carboxy terminal region. (1995) (15)
- An analysis of a wrong Nobel Prize-Johannes Fibiger, 1926: a study in the Nobel archives. (2004) (15)
- Upregulation of LMP1 Expression by Histone Deacetylase Inhibitors in an EBV Carrying NPC Cell Line (2004) (15)
- Prostate cancer cells specifically reorganize epithelial cell-fibroblast communication through proteoglycan and junction pathways (2017) (15)
- EBV specific killer T cells and serologic responses after onset of infectious mononucleosis. (1978) (15)
- Epstein-Barr virus co-reconstituted with Sendai virus envelopes infects Epstein-Barr virus-receptor negative cells. (1981) (15)
- Effect of transforming growth factor-beta 1 and -beta 2 on the proliferation of Burkitt lymphoma and lymphoblastoid cell lines. (1991) (15)
- Serological detection of a polyoma‐tumor‐associated membrane antigen (1979) (15)
- EBV-activation of human B-lymphocytes. (1986) (15)
- The evolution of independence from specific growth stimulation and inhibition in mammalian tumour-cell populations. (1957) (15)
- Multistep evolution of B-cell-derived tumors in humans and rodents. (1993) (15)
- Improved subtractive suppression hybridization combined with high density cDNA array screening identifies differentially expressed viral and cellular genes. (2003) (15)
- Identification of new tumor suppressor genes based on in vivo functional inactivation of a candidate gene (1999) (15)
- Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft. (1995) (15)
- Isolation and chromosomal localization of a new human retinoblastoma binding protein 2 homologue 1a (RBBP2H1A) (2000) (15)
- Variations in the sialic acid compositions in glycoproteins of mouse ascites tumor cell surfaces. (1979) (15)
- Somatic cell hybrids between human lymphoma cell lines. V. IdUrd inducibility and P3HR‐1 superinfectability of Daudi/HeLa (DAD) and Daudi/P3HR‐1 (DIP‐1) cell lines (1978) (15)
- The strange road to the tumor-specific transplantation antigens (TSTAs). (2001) (15)
- The nature of mammalian lymphosarcoma transmission by isolated chromatin fractions. (1952) (15)
- Comparative action of myc and bcl-2 in B-cell malignancy. (1991) (14)
- Nasopharyngeal carcinoma (NPC) is an enigmatic tumor. (2002) (14)
- T‐cell‐mediated inhibition of EBV‐induced B‐cell transformation: Recognition of virus particles (1988) (14)
- Chromosome banding, isoenzyme studies and determination of epstein‐barr virus DNA content on human burkitt lymphoma/mouse hybrids (1977) (14)
- Expression of Epstein-Barr-virus-associated membrane antigen in Raji cells superinfected with two different virus strains. (1976) (14)
- Cell stemness is maintained upon concurrent expression of RB and the mitochondrial ribosomal protein S18-2 (2020) (14)
- B cell-specific activation of the Epstein-Barr virus-encoded C promoter compared with the wide-range activation of the W promoter. (1996) (14)
- Effects of dimethyl sulfoxide treatment on H-2 expression and susceptibility to NK- or cytotoxic T-lymphocyte-mediated lysis of the YAC-1 lymphoma and its beta 2-microglobulin-deficient variant. (1988) (14)
- The microcell hybrid‐based “elimination test” identifies a 1‐Mb putative tumor‐suppressor region at 3p22.2–p22.1 centromeric to the homozygous deletion region detected in lung cancer (2002) (14)
- Polyomavirus persists in CD4/8 double-knockout, but not in CD4 or CD8 single-knockout mice. (1995) (14)
- Isolation and characterization of an adherent, 8-azaguanine resistant variant of the Burkitt lymphoma cell line, Raji. (1973) (14)
- Stimulation of human peripheral blood lymphocytes by autologous EBV-infected B cells. (1978) (14)
- Aberrant class switching juxtaposes c-myc with a middle repetitive element (LINE) and an IgH intron in two spontaneously arising rat immunocytomas. (1988) (14)
- Changes in the expression of Fc receptor produced by induction of Epstein-Barr virus in lymphoma cell lines. (1982) (14)
- A 53-kilodalton protein common to chemically and virally transformed cells shows extensive sequence similarities between species. (1982) (14)
- Direct membrane fluorescence reaction of EBV‐carrying human lymphoblastoid cells: Blocking tests with xenogeneic antisera (1969) (14)
- Origin of lymphoid lines established from mixed cultures of cord‐blood lymphocytes and explants from infectious mononucleosis, burkitt lymphoma and healthy donors (1975) (13)
- Stable transfection of a human lymphoma line by sub‐genomic fragments of Epstein‐Barr virus DNA to measure humoral and cellular immunity to the corresponding proteins (1987) (13)
- Genetic control of “natural” killer lymphocytes in the mouse (1975) (13)
- Comparison between two antibody populations in the EBV system: Anti‐MA Versus neutralizing antibody activity (1976) (13)
- Suppressor T cells activated by lymphoblastoid cell lines inhibit pokeweed mitogen-induced immunoglobulin synthesis. (1981) (13)
- Differences in EBV receptor concentration between in vitro EBV‐converted lymphoma sublines reflect biological differences between the converting viral substrains (1979) (13)
- Flow karyotype analysis and fluorescence‐activated sorting of burkitt‐lymphoma‐associated translocation chromosomes (1983) (13)
- Acetic acid treatment denatures DNA while preserving chromosomal morphology during the in situ hybridization procedure. (1978) (13)
- Serological reactivities of human and baboon sera against EBNA and Herpesvirus papio-determined nuclear antigen (HUPNA). (1978) (13)
- Malignant cells isolated from Burkitt's lymphoma but not other forms of leukemia activate the alternative complement pathway in human serum (1981) (13)
- Immunophenotypic characterization of follicle‐center‐cell‐derived non‐hodgkin's lymphomas (1989) (13)
- Enrichment of Helix pomatia (HP) lectin binding variant from the TA3St mouse ascites tumor by repeated column selection. (1978) (13)
- SH2D1A expression reflects activation of T and NK cells in cord blood lymphocytes infected with EBV and treated with the immunomodulator PSK. (2002) (13)
- Natural resistance against tumors grafted into the brain in association with histocompatibility‐class‐I‐antigen expression (1996) (13)
- Suppression and reappearance of N-tropic L virus production in somatic cell hybrids after introduction and loss of chromosomes carrying Fv-1b. (1980) (13)
- Rejectability of virus-induced tumors and nonrejectability of spontaneous tumors-a lesson in contrasts. (1977) (13)
- Human B lymphocytes activated by Epstein-Barr virus (EBV) or by mitogens suppress mitogen-induced immunoglobulin production. (1981) (13)
- Complement-Fixation Test for Detection of Herpes-like Viruses in Cell Cultures of Burkitt's Lymphoma (1969) (13)
- Genetic determinants of morphological differentiation in hybrid tumors. (1972) (13)
- Autonomy of H-2 Genes in Individual Immunocytes (1967) (13)
- Chromosomal, histopathological and cell surface marker studies on Moloney virus induced lymphomas. (1981) (12)
- The role of chromosome 15 in murine leukemogenesis. II. Relationship between tumorigenicity and the dosage of lymphoma vs. normal‐parent‐derived chromosomes 15 in somatic cell hybrids (1987) (12)
- Multistep emancipation of tumors from growth control: can it be curbed in a single step? (1990) (12)
- Some recent studies on the production and growth characteristics of ascites tumors (2004) (12)
- Role of p53 mutation in polyomavirus-induced tumorigenesis. (1997) (12)
- S18 family of mitochondrial ribosomal proteins: evolutionary history and Gly132 polymorphism in colon carcinoma (2016) (12)
- Hybrid cells derived from fusion of TA2-Ha ascites carcinoma with normal fibroblasts. II. Characterization of isoantigenic variant sublines. (1973) (12)
- Involvement of 3p Deletions in Sporadic and Hereditary Forms of Renal Cell Carcinoma (1991) (12)
- Elevated expression of c-myc and N-myc produces distinct changes in nuclear fine structure and chromatin organization. (1988) (12)
- Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines. (1993) (12)
- Antibodies of predetermined specificity for the NH2 terminus of a cellular protein p53 react with the native molecule: evidence for the presence of different p53s. (1983) (12)
- Mapping ofLmyc andNmyc to rat chromosomes 5 and 6 (1987) (11)
- The apoptosis modulating role of SAP (SLAM associated protein) contributes to the symptomatology of the X linked lymphoproliferative disease (2009) (11)
- Epstein-Barr virus (EBV)-specific cell-mediated and humoral immune responses in ataxia-telangectasia patients (1984) (11)
- Differences in C‐myc and pvt‐1 amplification in sewa sarcoma sublines selected for adherent or non‐adherent growth (1990) (11)
- Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growth (2015) (11)
- Superinfection of polyma-induced mouse tumors with polyoma virus in vitro. (1960) (11)
- Epstein‐barr virus in somatic cell hybrids between mouse cells and human nasopharyngeal carcinoma cells (1978) (11)
- Effect of TGF‐β1 on the ebv‐induced transformation of human lymphocyte cultures (1992) (11)
- The uterine cervix--a new member of the family of immunologically exceptional sites? (2003) (11)
- Epstein–Barr virus (EBV) provides survival factors to EBV+ diffuse large B‐cell lymphoma (DLBCL) lines and modulates cytokine induced specific chemotaxis in EBV+ DLBCL (2017) (11)
- Immunology: Sinking surveillance's flagship (1998) (11)
- Malignant lymphoma of “burkitt type” in Sweden. Lymphome malin de “type Burkitt” en suède (1967) (11)
- The effect of myc proteins on SV40 replication in human lymphoid cells. (1990) (11)
- Detection localization of Epstein-Barr virus-associated early antigens in single cells by autoradiography using 125I-labeled antibodies. (With 1 color plate). (1977) (11)
- Immunological studies on a case of recurrent Burkitt's lymphoma during immune stimulant treatment (1973) (11)
- Cell surface glycoprotein changes in Epstein‐Barr virus‐positive and ‐negative human hematopoietic cell lines (1979) (11)
- Effect of beta-lymphocyte- and NPC-derived EBV-LMP1 gene expression on in vitro growth and differentiation of human epithelial cells. (1994) (11)
- Production of leukocyte migration inhibitory factor (LIF) in human lymphocyte subsets exposed to polyclonal activators. (1984) (11)
- Nucleotide sequence of the rat Bmyc gene. (1989) (11)
- Multipoint interphase FISH analysis of chromosome 3 abnormalities in 28 childhood AML patients (2006) (11)
- EBNA promoter usage in ebv‐negative burkitt lymphoma cell lines converted with a neomycin‐resistant EBV strain (2001) (11)
- Analysis of c-Myc domains involved in stimulating SV40 replication. (1993) (11)
- Difference in viral binding between two epstein‐barr virus substrains to a spectrum of receptor‐positive target cells (1981) (11)
- Differential immunogenicity of Epstein-Barr virus (EBV) encoded growth transformation-associated antigens in a murine model system. (1997) (11)
- Tumorigenicity of EBV‐carrying lymphoblastoid cell lines (LCLS): Distinctive grading in scid mice (1991) (11)
- Differential expression of HLA antigens on human B-cell lines of normal and malignant origin: a consequence of immune surveillance or a phenotypic vestige of the progenitor cells? (1988) (11)
- Detection of polyoma‐virus‐induced tumor antigen(S) by macrophage migration inhibition (1982) (10)
- Surface antigens on lymphoblastoid cells derived from nasopharyngeal carcinoma. (1970) (10)
- Ratc-raf oncogene is located on chromosome 4 and may be activated by sequences from chromosome 13 (1988) (10)
- A case of an Epstein--Barr virus (EBV) genome-carrying lymphoma in an Israeli Arab child. (1977) (10)
- Immunological studies on Burkitt's lymphoma. (1971) (10)
- Jumping translocation of 17q11∼qter and 3q25∼q28 duplication in a variant Philadelphia t(9;14;22)(q34;q32;q11) in a childhood chronic myelogenous leukemia (2006) (10)
- Effects on apoptosis, cell cycle and transformation, and comparative aspects of EBV with other known DNA tumor viruses (2007) (10)
- Presence of erythrocytic components in the K562 cell line (1979) (10)
- H-2-associated control of natural cytotoxicity and hybrid resistance against RBL-5 (1978) (10)
- Role of EBV and Ig/myc translocation in Burkitt lymphoma. (1994) (10)
- Autoradiographic detection of Epstein-Barr virus (EBV)-associated early antigen in a variety of EBV DNA-containing lymphoblastoid cell lines previously designated as nonproducers. (1978) (10)
- Effect of retinoic acid (RA) on the Epstein-Barr virus (EBV)-inducing effect of sodium butyrate. (1980) (10)
- EBV Infection Induces Expression of the Transcription Factors ATF-2/c-Jun in B Lymphocytes but not in B-CLL Cells (2005) (10)
- Epithelial Characteristics of Tumor Cells in Nasopharyngeal Carcinoma Passaged in Nude Mice: Ultrastructure (1976) (10)
- Reactivity of radioiodinated serum antibody from Burkitt's lymphoma and nasopharyngeal carcinoma patients against culture lines derived from Bukrkitt's lymphoma. (1970) (10)
- Molecular Weight Variation of EBNAs as a Means to Identify Different Epstein-Barr Virus Isolates (EBNotyping) (1989) (10)
- How one thing has led to another. (1989) (10)
- Molecular size variation of EBNA is determined by the EB viral genome. (1984) (10)
- The presence of Moloney virus induced antigen on antibody-producing cells. (1970) (10)
- Demonstration of complement receptors on lymphoblastoid cells by radiolabeled antibodies and in situ autoradiography. (1977) (10)
- The EBV-carrying, beta2M/HLA deficient Burkitt lymphoma line Daudi is sensitive to EBV-specific killer T-cells of mononucleosis patients. (1979) (10)
- Studies on the polyoma tumor‐specific transplantation antigen (TSTA): Selection and characterization of TSTA‐negative segregants from somatic hybrids (1987) (10)
- Epstein-Barr virus-associated and other antiviral antibodies during intense BCG administration to patients with Burkitt's lymphoma in remission. (1978) (10)
- Robertsonian translocation studies on the significance of trisomy 15 in murine T-cell leukemia. (1983) (10)
- Plasmacytoma induction in radiochimeras (1989) (10)
- Drosophila homolog of the murine Int-1 protooncogene. (1988) (10)
- Studies on the B lymphoblast antigen No. 1 (BB-1) on a series of Burkitt lymphoma lines differing in the expression of the EBV/C3 receptor complex. (1983) (10)
- S(+) versus racemic ibuprofen (1992) (10)
- Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation. (1990) (10)
- Foulds' dangerous idea revisited: the multistep development of tumors 40 years later. (1998) (9)
- PROTECTIVE EFFECT OF MURINE SARCOMA VIRUS‐SUPEREVFECTED MOUSE TUMOR CELLS AGAINST OUTGROWTH OF CORRESPONDING NONINFECTED TUMOR (1978) (9)
- III. HYB RIDS BETWEEN DIPLOID FIBROBLASTS AND OTHER TUMOUR CELLS (1971) (9)
- ‘Hybrid resistance’ against parental tumors: One or several genetic patterns? (1978) (9)
- Adult X-linked immunodeficiency (XID) mice, IGM-/- single knockout and IGM-/- CD8-/- double knockout mice do not clear polyomavirus infection. (1998) (9)
- Light and heavy chains specifying a human IgMκ autoantibody to a T-cell receptor Vβ-antigen (1993) (9)
- EBV-B cell interactions: Immortalization, rescue from apoptosis, tumorigenicity (2007) (9)
- Expression of polyoma-induced antigens in low malignant hybrids derived from fusion of a polyoma-induced tumour with a fibroblast line (1974) (9)
- Hybrid resistance against a natural killer (NK) cell-resistant lymphoma (YWA) is mediated by a T cell-dependent mechanism. (1982) (9)
- Natural killer cell sensitivity of human lymphoid lines of B-cell origin does not correlate with tumorigenicity or with the expression of certain differentiation markers. (1984) (9)
- Allele‐specific loss or imbalance of chromosomes 9, 15, and 16 in B‐cell tumors from interspecific F1 hybrid mice carrying eμ‐c‐myc or N‐myc transgenes (2000) (9)
- Epstein‐Barr virus (EBV) gene expression in lymphoid B cells during acute infectious mononucleosis (IM) and clonality of the directly growing cell lines (1997) (9)
- The “missing” mouse plasmacytoma (MPC) associated translocation T(15;16) occurs repeatedly in new MPC induction systems (1990) (9)
- Enzyme-linked immunosorbent assay for the detection of Epstein-Barr virus-induced antigens and antibodies. (1983) (9)
- Detection of a nuclear antigen in Herpesvirus ateles-carrying marmoset lines by the acid-fixed nuclear binding technique. (1979) (9)
- Functional and molecular characterization of B cell-responsive V delta 1+ gamma delta T cells. (1994) (9)
- Appearance and distribution of virally determined antigens in lymphoid organs of mice during leukemogenesis by Moloney leukemia virus. (1980) (9)
- Insulin receptors on human lymphoid lines of B-cell origin (1981) (9)
- Experimental appraisal of the lack of antitumor natural killer cell-mediated immunosurveillance in response to lymphomas growing in the mouse brain. (2003) (9)
- Optimisation of the degenerate oligonucleotide primed PCR (DOP-PCR) for capillary thermocycler. (2002) (9)
- In vitro derived mouse A9 cell clones differing in malignancy: analysis by somatic cell hybridization with YACIR lymphoma cell clones. (1976) (9)
- Chromosomes and cell surface markers of marmoset lymphocytes and Epstein-Barr virus-transformed marmoset cell lines. (1981) (9)
- Localization and quantitation of EBV-associated nuclear antigen (EBNA) in Raji cells. (1975) (9)
- Induction of Epstein-Barr virus-associated nuclear antigen during in vitro transformation of human lymphoid cells. (1975) (9)
- Host defenses in leukemia and Burkitt's tumor (1968) (9)
- Lymphoma Growth in vivo: Electronic Discrimination between Tumor and Stroma Cells (1965) (9)
- HL-A and Burkitt's disease. (2008) (8)
- Relationship between humoral antibodies and the failure to develop progressive tumors in cats injected with feline sarcoma virus (FSV). (1973) (8)
- PRIMA-1MET induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 protein (2009) (8)
- Detection of the Epstein-Barr virus-associated antigens EA (early antigen) and VCA (viral capsid antigen) by direct or indirect binding of iodinated antibodies to antigen immobilized in polyacrylamide gel. (1979) (8)
- Introduction: genetic and epigenetic contributions to tumor evolution. (2002) (8)
- Epstein-Barr virus, malaria and Burkitt's lymphoma. (1982) (8)
- Mandatory chromosomal segment balance in aneuploid tumor cells (2007) (8)
- Antibodies associated with Epstein-Barr virus in Burkitt's lymphoma during injections of BCG or irradiated autochthonous tumor cells. (1973) (8)
- Tumour suppressor genes (1988) (8)
- bcl‐2 rearrangement detected by pulsed‐field gel electrophoresis (PFGE) in B‐chronic lymphocytic leukemia (CLL) cells (1998) (8)
- Human T cell growth factor (TCGF) produced by repeated stimulation of non-adherent human lymphocytes. (1982) (8)
- Epstein‐Barr virus‐associated antibody pattern in untreated non‐Hodgkin lymphoma patients. Relationship to clinical variables and lymphocyte functions (1983) (8)
- Tumor-associated antigens in H-2 hemizygous isoantigenic variants of a somatic cell hybrid, derived from the fusion of a 3-methylcholanthrene-induced sarcoma and a mammary carcinoma. (1977) (8)
- Studies of epstein‐barr virus (ebv)‐associated nuclear antigen. I. Assay in human lymphoblastoid cell lines by direct and indirect determination of 125i‐igg binding (1975) (8)
- Burkitt's lymphoma cells: membrane properties and surface morphology as seen by scanning electron microscopy. (1979) (8)
- Rejection antigens in chemically induced tumors. (1997) (8)
- Different t‐cell subtypes are associated with pathologically distinct forms of moloney leukemia virus (m‐mulv)‐induced lymphoma (1982) (8)
- Implantation of mouse histocompatibility antigens into membranes of cultured tumor cells (1981) (8)
- Changed Fc and C3 receptor pattern on human EBV-negative lymphoma cells, following in vitro conversion by EB-virus. (1980) (8)
- EBV counteracts IL‐21‐induced apoptosis in an EBV‐positive diffuse large B‐cell lymphoma cell line (2013) (8)
- A technique for the identification of glycoprotein antigens in immune complexes and its application to the detection of a common glycoprotein in sera of patients with Burkitt's lymphoma and nasopharyngeal carcinoma. (1981) (8)
- Antigen-inducing ability of herpesvirus papio in human and baboon lymphoma lines, compared to Epstein-Barr virus. (1978) (8)
- The Epstein-Barr virus determined nuclear antigen is composed of at least three different antigens. (1986) (8)
- Enhanced H-2 expression and T-cell-dependent rejection after intracerebral transplantation of the murine lymphoma YAC-1. (1989) (8)
- Downregulation of c-myc expression after heat shock in human B-cell lines is independent of 5' mRNA sequences. (1995) (8)
- EBV and B Cell Lymphomas (2002) (8)
- Radioimmunoassay for Epstein--Barr virus (EBV)-associated nuclear antigen (EBNA). Binding of iodinated antibodies to antigen immobilized in polyacrylamide gel. (1977) (8)
- Tumor-host cell hybrids in radiochimeras reconstituted with bone marrow and thymus grafts (1976) (7)
- Cell surface characteristics of an allotransplantable TA3 ascites subline resulting from a process of immunoselection. (1983) (7)
- Genotypic and phenotypic characterization of two newly established renal cell carcinoma cell lines. (1996) (7)
- Moloney lymphoma cells express a polyprotein contanining the GAG gene‐coded p15 and the moloney leukemia virus‐induced cell surface antigen (MCSA) (1979) (7)
- Cell surface glycoprotein patterns of two EBV-negative lines and their EBV converted sublines. (1981) (7)
- Inhibition of DNA metabolism in human B lymphocytes by a substrain of Epstein-Barr virus (P3HR-1): a method for virus quantitation. (1978) (7)
- Immune interferon (IFN-γ) production in autologous mixed cultures (1983) (7)
- Lysis of P3HR-1 cells induced to enter the viral cycle by antibody-dependent and independent immunological mechanisms. (1989) (7)
- Tumor Associations of EBV--Historical Perspectives. (2015) (7)
- Immune recovery after bone marrow and peripheral blood stem cells transplantation. (1999) (7)
- Location of Myc, Igh, and Igk on Robertsonian fusion chromosomes is inconsequential for Myc translocations and plasmacytoma development in mice, but Rb(6.15)‐carrying tumors prefer Igk–Myc inversions over translocations (2005) (7)
- Purification and analysis of immune complexes with the aid of rheumatoid factor-coated tubes. (1981) (7)
- Epstein-Barr virus (EBV)-induced transformation of human lymphoid cells and immunosurveillance against lymphoma development. (1973) (7)
- Migration inhibition caused by ebv‐specific 48k subcomponent of ebna and the associated 53k cellular protein (1982) (7)
- In vitro produced monoclonal rheumatoid factor: purification, radiolabel, and possible applications. (1982) (7)
- Multipoint interphase FISH in childhood T-acute lymphoblastic leukemia detects subpopulations that carry different chromosome 3 aberrations. (2007) (7)
- EGNA-specific LIF production of human lymphocyte subsets. (1984) (7)
- The rat immunoglobulin kappa light chain locus is on chromosome 4 (2004) (7)
- Histochemical studies on the EBV-determined nuclear antigen (EBNA). (1977) (7)
- Detection of virus and cellular-determined antigens in situ using [125I]protein A and autoradiography. (1979) (7)
- Effects of sodium butyrate on human chronic myelogenous leukaemia cell line K562 (reply) (1979) (7)
- Biochemical characterization of Epstein-Barr virus nuclear antigen 2A and an associated ATPase activity. (1992) (7)
- Selection of a low antigenic variant subline from the TA3St ascites carcinoma by repeated passage of antibody-coated cells through anti-immunoglobulin columns. (1979) (7)
- Long-range restriction enzyme maps of DNF15S2, D3S2, and c-raf1 loci on the short arm of human chromosome 3. (1989) (7)
- Blood lymphocytes in infectious mononucleosis share the following characteristics with activated T cells: natural attachment, stable E rosetting and glucocorticoid sensitivity. (1980) (7)
- Cytogenetic replication studies on murine T-cell leukemias with special consideration to chromosome 15 (2004) (6)
- Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5. (1993) (6)
- Localization of the rat immunoglobulin heavy chain locus to chromosome 6 (1986) (6)
- Detection of mutant-specific responses by macrophage migration inhibition reactions induced by wild-type and mutant polyoma viruses and polyoma virus-infected cells. (1984) (6)
- Tumor resistance (2012) (6)
- Mechanisms of escape from immune surveillance. (1976) (6)
- Reactivity with patient antibodies of partially purified gp40 antigen from immune complexes in burkitt's lymphoma and nasopharyngeal carcinoma (1982) (6)
- Humoral immune response in Epstein-Barr virus infections. II. IgG subclass distribution in African patients with Burkitt's lymphoma and nasopharyngeal carcinoma. (1984) (6)
- Cytogenetic studies onH-2 alloantigenic loss variants selected from heterozygous tumors (1975) (6)
- The biology and serology of Epstein-Barr virus (EBV) infections. (1976) (6)
- The Epstein-Barr virus-determined nuclear antigen: a previously identified 48K component and higher-molecular-weight forms of the antigen are structurally related. (1983) (6)
- Immunological studies on Burkitt's lymphoma. (1971) (6)
- Coexistence in human sera of a cell (membrane?) ANTIGEN AND Of autoantibodies directed against it. (2008) (6)
- Summary of papers delivered at the Conference on Herpesvirus and Cervical Cancer (Key Biscayne, Florida). (1973) (6)
- Simian virus 40 and the human mesothelium. (2000) (6)
- Correlation between tumorigenicity and banding pattern of chromosome 15 in murine T-cell leukemia cells and hybrids of normal and malignant cells (2004) (6)
- The most frequently lost allelic site in human renal cell carcinoma (D3F15S2) on the short arm of chromosome 3 has homologous sequences on rat chromosome 8. (1991) (6)
- The role of viral transformation and cytogenetic changes in viral oncogenesis. (1979) (6)
- A new approach to gene mapping by in situ hybridization on isolated chromosomes (1985) (6)
- Demonstration of resistance against methyleholanthrene-inducedsarcomas in primary autochthonous hosts (1962) (6)
- Modern criteria to determine the etiology of human carcinogens. (2004) (6)
- State of Epstein-Barr virus DNA in an American Burkitt's lymphoma line. (1978) (5)
- Spontaneous development of plasmacytomas in a selected subline of BALB/cJ mice. (1997) (5)
- Nuclear receptors and their role in Epstein -- Barr virus induced B cell transformation. (2009) (5)
- Over‐expression of c‐myc increases the sensitivity of epstein‐barr virus immortalized lymphoblastoid cells to non‐MHC‐restricted cytotoxicity (2009) (5)
- Separation of cells with different histocompatibility (H‐2) antigens by passage through cellular immunoadsorbent columns (1977) (5)
- EBNA-5 , an Epstein-Barr virus-encoded nuclear antigen , binds to the retinoblastoma and p 53 proteins ( tumor suppressor proteins / viral strategy ) (2005) (5)
- A Plea for Justice for Jailed Medical Workers (2006) (5)
- Effect of TGF-beta 1 on the EBV-induced transformation of human lymphocyte cultures. (1992) (5)
- Burkitt lymphoma and genetic markers of immunoglobulin. (1986) (5)
- The replication activity of SV40 DNA correlates with the level of c-myc expression in human tumor cell lines. (1988) (5)
- Signal transduction pathways in Burkitt's lymphoma cell lines BL41 and DG75 with different sensitivity to doxorubicin. (2004) (5)
- Genetic differences in F1 hybrid resistance against tumours of the same parental strain. I. Tumours of C57Bl/6 origin. (1981) (5)
- Augmentation of leukocyte infiltration in murine tumors expressing B‐cell derived but not nasopharyngeal carcinoma derived EBV membrane protein LMP1 (2000) (5)
- Relationship between Herpesvirus ateles-associated nuclear antigen (HATNA) and the number of virus genome equivalents in HVA-carrying lymphoid lines. (1981) (5)
- Perspectives in CancerResearch Conditioned Tumorigenicity of Activated Oncogenes1 (1986) (5)
- Relationship between clinical stage, histopathology and antibody titers against the second epstein‐barr virus nuclear antigen (EBNA‐2) in non‐Hodgkin's lymphoma patients (1989) (5)
- Induction of anti-tumor activity following autologous stem cell transplantation: immunotherapeutic implications. (2001) (5)
- Multistep Scenarios in Tumor Development and the Role of Oncogene Activation by Chromosomal Translocations (1986) (5)
- Shedding of anti‐IgM from antibody‐coated human lymphoma lines: Differences between Epstein‐Barr virus‐negative lines and their virus‐converted sublines (1978) (4)
- Mixed Agglutination between Established Burkitt Cell Lines and Fresh Biopsy Specimens (1967) (4)
- Autologous lymphokine-activated killer (LAK) cell therapy of EBV+ and EBV- lymphoproliferative disorders arising in organ transplant recipients (1997) (4)
- Decreased sensitivity of immunoselected and NK-selected YAC lymphoma sublines to hybrid resistance in vivo. (1982) (4)
- Detection of a polyoma virus-induced tumor-associated membrane antigen in mouse cells by the macrophage migration inhibition test. (1986) (4)
- Epstein-Barr virus-encoded LMP-1 protein upregulates the pNDCF group of nucleoskeleton-cytoskeleton-associated proteins. (1997) (4)
- Studies of Epstein-Barr virus (EBV)-associated nuclear antigen: solubilization from Raji cell chromatin with 5 M-urea-2 M-nacl and fractionation on hydroxyapatite. (1978) (4)
- Requirement of the CD8+ or CD4+ T lymphocyte subsets for the rejection of lymphoma and fibrosarcoma grafts studied in gene knockout hosts. (1998) (4)
- Reduced humoral and cellular cytotoxic sensitivity in major histocompatibility variants of the YAC (Moloney) lymphoma (2005) (4)
- Unsung Hero Robert C. Gallo (2009) (4)
- Immunoprecipitation of Epstein-Barr virus EBNA1 protein using human polyclonal serum. (1986) (4)
- COMPLEXITY OF ANTIGEN‐ANTIBODY SYSTEMS ASSOCIATED WITH EPSTEIN‐BARR VIRUS * (1971) (4)
- Cell phenotype (CD23)‐dependent variation in EBV genome copy numbers within lymphoblastoid cell lines (LCL) (1992) (4)
- Detection and characterization of EBV antigens by micro-ELISA and chromatofocusing. (1982) (4)
- Ig/myc translocations of the plasmacytoma‐prone BALB/c strain occur independently of the genetic and parental origin of the affected chromosomes 6, 12, and 15 (1996) (4)
- Antibodies in human sera against the Epstein-Barr virus encoded latent membrane protein (LMP). (1988) (4)
- Flow cytometric analysis of lymphocyte subsets as a predictive factor for GVHD in allogeneic bone marrow transplantation. (1999) (4)
- Fc and C3 receptor patterns on two EBV- negative Burkitt lymphoma lines during acute exposure to EBV (P3HR-1 substrain). (1981) (4)
- Physicochemical and morphological characterization of a new allotransplantable mammary carcinoma ascites subline, TA3-St/ticol/-A. (1983) (4)
- Elongated mouse chromosomes suitable for enhanced molecular cytogenetics (2004) (4)
- The role of humoral immunity and the contribution of the F1 anti-parental effect in the rejection of a moloney leukemia virus-induced lymphoma graft (2004) (4)
- DIFFERENT SENSITIVITY OF B CELL LINES DERIVED FROM BURKITT LYMPHOMA (BL) AND NORMAL CELLS (LCL) TO CYTOTOXIC T CELL CLONES GENERATED BY AUTOLOGOUS AND ALLOGENEIC STIMULATION (1986) (4)
- The Epstein-Barr virus ZEBRA protein activates transcription from the early lytic F promoter by binding to a promoter-proximal AP-1-like site. (2002) (4)
- The rat MIS1/Pvt-1 locus is syntenic with MYC on chromosome 7. (1987) (4)
- CIS – Cloning of Identical Sequences Between Two Complex Genomes (2004) (4)
- Proteins in normal and malignant cells, cross‐reacting with the latent membrane protein encoded by Epstein‐Barr virus (1988) (4)
- Independent variations of myc amplification, inducibility, maturation, and proliferation states in HL60. (1988) (4)
- Epstein-Barr virus, infectious mononucleosis, Burkitt's lymphoma and nasopharyngeal carcinoma. (1977) (4)
- [Better understanding of the biology of cancer cells]. (2000) (3)
- Epstein-Barr Virus (EBV) Specific T and K Cell Cytotoxicity in vitro1 (1976) (3)
- The natural attachment of thymocytes and activated T lymphocytes to normal and malignant cells: an interspecies study. (1980) (3)
- erratum: Elevated c-myc expression facilitates the replication of SV40 DNA in human lymphoma cells (2001) (3)
- Immuno-fluorescence and immuno-electron microscopy on EBV-associated membrame antigen of a nasopharyngeal carcinoma derived lymphoblastoid cell line (LY-28). (1974) (3)
- Plasmacytoma induction in specific pathogen-free (SPF) bcl-2 transgenic BALB/c mice. (1999) (3)
- Selective inhibitory effect of Hu-IFN-gamma on the agarose clonability of tumor-derived lymphoid cell lines. (1985) (3)
- Serological definition of individually distinct surface antigens in mouse mammary carcinomas. (1980) (3)
- Sapporo Cancer Seminar: Escape of Tumor Cells from Immune Controls (1982) (3)
- Chromosomal translocations in B-cell derived tumors. (1987) (3)
- Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity. (1985) (3)
- V‐ABL does not abolish IL‐6 requirement by murine plasmacytoma cells (1991) (3)
- Analysis of Epstein-Barr virus-specific and non-specific immune functions in a patient during the development of a non-Hodgkin's lymphoma. (1987) (3)
- SOME FEATURES OF TUMOR‐SPECIFIC ANTIGENS: A GENERAL DISCUSSION (1962) (3)
- Alloantigenic variant selection in vitro from a mouse lymphoma — Sarcoma hybrid (1974) (3)
- Distinct Functions of Protein Kinase Ca and Protein Kinase Cu during Retinoic Acid-induced Differentiation of F 9 Cells 1 (2005) (3)
- An exceptional mouse plasmacytoma with a new kappa/N-myc [T(6; 12) (C1; B)] translocation expresses N-myc but not c-myc. (1992) (3)
- Immune resistance of semisyngeneic F1 hybrid mice to lymphoma grafts differs from natural hybrid resistance in its genetic pattern. (1984) (3)
- Variation in cell populations of transplanted tumors as indicated by studies on the ascites transformation. (1955) (3)
- Cancer, viruses and environmental factors. (1978) (3)
- The rise and fall of central dogmas (2016) (3)
- Epstein Barr virus (EBV) carrying cells in blood of Hodgkin's disease (HD) and non-Hodgkin lymphoma (NHL) patients with high antibody titers against EBV capsid antigens (VCA). (1990) (3)
- Jumping translocation of 17q11 approximately qter and 3q25 approximately q28 duplication in a variant Philadelphia t(9;14;22)(q34;q32;q11) in a childhood chronic myelogenous leukemia. (2006) (3)
- The increased natural killer sensitivity of Epstein-Barr virus (EBV)-superinfected Raji cells is not due to the recognition of serologically determined EBV antigens by the effectors. (1982) (3)
- Moloney murine leukemia virus variants with distinct p30 peptide maps are associated with different clinical types of leukemia. (1981) (3)
- Malignant lymphoma of "Burkitt type" in Sweden. (1967) (3)
- Localization of the rat immunoglobulin lambda light chain locus to chromosome 11 (2004) (3)
- Oncogene Activation by Chromosomal Translocations in B Cell-Derived Tumors (1986) (3)
- Principles of Human Tumor Virology (2007) (3)
- Evidence for antigenic distinctness of the Epstein--Barr virus-determined nuclear antigen and the Herpesvirus papio-determined nuclear antigen. (1979) (3)
- Differential expression of nucleoskeleton- and cytoskeleton-associated proteins in Burkitt lymphoma-derived and Epstein-Barr virus-immortalized lymphoblastoid cell lines. (1997) (3)
- Multiple myeloma and Kaposi's sarcoma-associated herpesvirus--a paracrine model of tumorigenesis? (1997) (3)
- Immunological aspects of B-cell derived tumors in humans and rodents. (1988) (3)
- Interaction of Herpesvirus Ateles and Herpesvirus Saimiri with Primate Lymphocytes (1980) (3)
- The Epstein-Barr virus (EBV): evidence for EBV strains. (1975) (3)
- Genetic determinants of morphological differentiation in a lymphoma‐sarcoma hybrid (1975) (3)
- Mapping of a new MAP kinase activated protein kinase gene (3PK) to human chromosome band 3p21.2 and ordering of 3PK and two cosmid markers in the 3p22–p21 tumour-suppressor region by two-colour fluorescencein situ hybridization (1996) (3)
- Herpesvirus papio: state of viral DNA in baboon lymphoblastoid cell lines. (1978) (3)
- c-myc activation in spontaneous rat immunocytomas containing a 6;7 chromosomal translocation. (1986) (3)
- Production of rabbit antibodies against the viral capsid antigen (VCA) of the epstein‐barr virus (EBV) (1978) (3)
- Inositol derivatives down-regulate c-myc inducing growth arrest without differentiation. (1991) (3)
- Modern criteria to establish human cancer etiology. (2004) (3)
- Hypersomy of chromosome 15 with retrovirally rearranged c-myc, loss of germline c-myc and IgK/c-myc juxtaposition in a macrophage-monocytic tumour line. (1994) (3)
- ADVANCES IN CANCER RESEARCH. VOLUME 14. (1965) (3)
- Incidence and type of tumors induced by DMBA carcinogenesis in H‐2 congenic strains on a B10 background (1983) (3)
- The tale of the great cuckoo egg (1999) (3)
- Summary: Antigens of Chemically Induced Tumors; and Search for Tumor-specific Antigens in Other Human Cancers (1968) (2)
- Interaction of SEWA sarcoma cell proteins with the intracisternal A‐type particle long terminal repeat dna sequence (1992) (2)
- Antibodies to Cell Organoids in the Sera of Nasopharyngeal Carcinoma Patients and of Systemic Lupus Erythematosus Patients (1973) (2)
- The Ig/myc Translocation in Burkitt’s Lymphoma Is a Rate Limiting Step in Tumor Development with Multiple Phenotypic Consequences (1989) (2)
- Serologically defined, unique surface antigen on a mouse mammary adenocarcinoma. (1979) (2)
- A Cellular and Molecular Foundation for Understanding Cancer (2006) (2)
- Classification of lymphocytes in naso pharyngeal carcinoma biopsies (1975) (2)
- Interaction of Herpesvirus ateles and Hepesvirus saimiri with primate lymphocytes. I. Selective adsorption of virus by lymphoid cells. (1980) (2)
- Interaction of herpesvirus ateles with marmoset lymphocytes. II. Identification of target cell population and stimulation of DNA synthesis after infection in vitro. (1980) (2)
- Solubilization of IgM-κ specific surface material from Burkitt lymphoma cell lines (1971) (2)
- Efficient retroviral transfer of a mouse c-myc construct into HL60. (1989) (2)
- Interaction between Epstein-Barr virus-determined nuclear antigen (EBNA) and the viral DNA. (1984) (2)
- Stimulation of lymphocytes in vitro to reactions against cultured Burkitt's lymphoma cells. (1973) (2)
- Immune and non-immune surveillance in cancer (2013) (2)
- The use of histocompatibility genes as markers for the study of isoantigenic variation in populations of tumor cells. (1959) (2)
- Surgace IgM specificity on cells derived from a Burkitt's lymphoma. (1967) (2)
- Epstein Barr virus (EBV)-carrying cells of a chronic lymphocytic leukemia (CLL) subpopulation express EBNA1 and LMPS but not EBNA2 in vivo. (1996) (2)
- HYBRID RESISTANCE TO PARENTAL TUMORS: INFLUENCE OF HOST AND TUMOR GENOTYPE AND TUMOR DERIVATION (1980) (2)
- Reversion of tumorigenicity in an EBV-converted Burkitt's lymphoma line. (1989) (2)
- Tumorgenicity of L cell derivatives and hybrid cells derived from them. (1976) (2)
- Detection of the EBV-determined nuclear antigen (EBNA) in Burkitt's lymphoma and nasopharyngeal carcinoma biopsies by the acid fixed nuclear binding (AFNB) technique. (1978) (2)
- Studies on the possible chemical, immunochemical and morphological differences at the cell surfaces of immunosensitive and immunoresistant, Moloney virus-induced, lymphoma cell-lines. (1983) (2)
- Physiology or Medicine 1980 (1992) (2)
- Epstein-Barr virus-specific leukocyte migration inhibition reaction with tumor biopsy extracts: correlation with the presence of viral DNA. (1983) (2)
- Inhibitory effect of lymphocytes on DNA synthesis of target cells in vitro. (1966) (2)
- Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells. (1972) (2)
- The transmembrane protein TMEM7 is an IFN- α responsive gene that suppresses cell proliferation and is down-regulated in human hepatocellular carcinoma (2007) (2)
- Cooperativity between stromal cytokines drives the invasive migration of human breast cancer cells (2019) (2)
- Differential expression of N-myc, c-myc and c-src proto-oncogenes during the course of induced differentiation of murine embryonal carcinoma cells. (1986) (2)
- In frame deletion of intron-7 in the p53 gene in a human tonsil tumor. (1995) (2)
- Column selection of antigenic variants from tumors. YAC (Moloney) lymphoma variants with reduced antigen expression (1979) (2)
- The virology and immunology of Burkitt's lymphoma in Africa and the need for corresponding studies in the high endemic regions of Papua New Guinea. (1978) (2)
- Multiple Factors Involved in B-Cell Tumorigenesis (1986) (2)
- Cell surface antigen expression in cytoplasts and karyoplasts of mouse L cells. (1978) (2)
- The relative role of viral transformation and specific cytogenetic changes in the development of murine and human lymphomas. (1981) (2)
- Expression and chromosomal assignment of a novel protein-tyrosine kinase gene related to the insulin receptor family. (1989) (2)
- Tumor Suppressor Genes: Specific Classes (2002) (2)
- Viruses as the Causative Agents of Naturally Occurring Tumors (1985) (2)
- A splice donor site mutation results in the insertion of five extra amino acids into P53 from SEWA mouse sarcoma cells. (1995) (2)
- A murine plasmacytoma with a variant (15;16)(D2/3;B1) translocation that involves the c-myc and lambda light chain gene-carrying chromosomes. (1990) (2)
- Superinfection of EBV-carrying lines with herpes virus papio (HVP): induction of early antigen (EA) and inhibition of cellular DNA synthesis. (1979) (2)
- Chromosomal translocations in B-cell derived tumors. (1986) (1)
- [Experimental analysis of intracerebral natural resistance against H-2+ and H-2- lymphomas grafted into the brain]. (1989) (1)
- The scientist as a poet (2000) (1)
- Mechanisms of Carcinogenesis1 (1975) (1)
- Effect of mitomycin C and hydroxyurea on the expression of the Epstein-Barr virus cycle following P3HR-1 superinfection. (1980) (1)
- C2-activating proteases on human lymphoblastoid cells superinfected with epstein-barr virus. (1980) (1)
- Immunochemical characterization of EBV antigens detected by double immunodiffusion. (1982) (1)
- The immunology of host–tumour relationships (reply) (1985) (1)
- Solubilisation of Epstein-Barr virus (EBV)-associated nuclear antigen from Raji cells and chromatin by treatment with various molarities of NaCl. (1977) (1)
- Non-Random Chromosome Changes Involving the Distal End of Chromosome 15 and Chromosomes 6 and 12 in Pristane-Induced Mouse Plasmacytomas (1980) (1)
- Suppressor T cells activated by autologous B-cell derived lines inhibit blastogenic responses by peripheral lymphocytes to mitogens or autologous lymphoblastoid cell lines. (1982) (1)
- Immunological Control of EBV Infected B Cells (1983) (1)
- Low-molecular-weight (61K) mu chain in P3HR-1 cells and various derived somatic hybrids. (1983) (1)
- Mapping of 22Notl linking clones on human chromosome 3 by polymerase chain reaction and somatic cell hybrid panels (2005) (1)
- T lymphocyte culture established by repeated stimulation with the autologous lymphoblastoid line. MHC class II restricted interactions with B blasts. (1984) (1)
- The Capacity of Lymphoblastoid Cells to Activate the Alternative Complement Pathway Is Correlated with their Transformation by Epstein-Barr Virus (1978) (1)
- B-cell neoplasia in a developmental framework. (1995) (1)
- Mouse plasmacytoma associated (MPC) T(15;16) translocation occurs repeatedly in new MPC induction system. (1990) (1)
- Host defense mechanisms and immunopotentiators : Proceedings of a workshop held at the 14th International Congress of Chemotherapy, Kyoto, 1985 (1986) (1)
- Genetic control of in vitro NK-activity and in vivo resistance to tumors. (1983) (1)
- derived mononuclear cell cultures - EBV-infected cord blood Leukotriene B4 activates T cells that inhibit B-cell proliferation in (2013) (1)
- THE ANALYSIS OF MALIGNANCY BY CELL FUSION (2005) (1)
- Studies on Malignant Behavior and Antigen Expression in Cell Hybrids (1972) (1)
- Epstein–Barr Virus (EBV) (2001) (1)
- Antibodies to Epstein-Barr virus associated antigens in Burkitt's lymphoma. (1973) (1)
- Expression of the Epstein‐Barr virus encoded EBNA‐I gene in stably transfected human and murine cell lines (1988) (1)
- Advances in Cancer Research: Centennial Volume. Introduction. (2008) (1)
- Lymphocytes and Antibodies in Relation to Malignant Disease (2008) (1)
- Torbjörn Caspersson, 15 October 1910 - 7 December 1997. (2003) (1)
- Epstein-Barr virus (EBV) specific T and K cell cytotoxicity in vitro. (1975) (1)
- Genetic studies on natural resistance to Moloney lymphoma (YAC) isografts. I. Introduction of a non-H-2-linked resistance gene on strain A/Sn background (2004) (1)
- Plasmacytoma induction in BALB/c6;15----DBA/2 chimeras. (1990) (1)
- Oncogene Activation by Chromosomal Translocations (1985) (1)
- Solid-phase radioimmunoassay for Epstein-Barr virus-associated membrane antigen prepared from B95-8 cell culture supernatants. [/sup 125/I tracer technique] (1977) (1)
- Differential expression and localization of EBER-1 and EBER-2 in Epstein-Barr virus-carrying cells. (1998) (1)
- Identification of recognition sites for Myc/Max/Mxd network proteins by a whole human chromosome 19 selection strategy (2008) (1)
- Recombinant plasmid expressing the entire coding region of the Bmyc putative protein. (1990) (1)
- Antigenic behavior of Moloney virus-induced lymphomas in mice. (1966) (1)
- Epstein-Barr virus-associated membrane-reactive antibodies during long term survival Burkitt's lymphoma. (1974) (1)
- The nucleic acid content and the growth rate of mouse ascites tumor cells. (1951) (1)
- Tumour-associated antigens. Potential application in research, tumour therapy and tumour prevention. (1972) (1)
- Immune interferon (IFN-gamma) production in autologous mixed cultures. (1983) (1)
- Lymphocyte-mediated lysis of autologous and allogeneic B-cell lines in man. (1983) (1)
- T-cell-dependent hybrid resistance against a natural killer-resistant Moloney virus-induced lymphoma (YWA): in vitro generation of cytotoxic lymphocytes. (1984) (1)
- Significance of the Cellular Antigens in Burkitt’s Lymphoma (1972) (0)
- 346 CELLS TRANSYORMED BY MURINE SARCOMA (2003) (0)
- The Reticuloendothelial Society: tenth international congress. Kawana Hotel, Ito, Japan, September 2–7, 1984 (1984) (0)
- Genetic Interaction Between Proto-Oncogene and Histocompatibility Antigen Gene Expressions in Cellular Differentiation of Mouse Neuroblastoma (1991) (0)
- Krev-1: the first transformation suppressor gene isolated by expression cloning. (1991) (0)
- Sixth Sapporo Cancer Seminar. (1987) (0)
- The 20th International Symposium of the Princess Takamatsu Cancer Research Fund on "Genetic Basis for Carcinogenesis: tumor suppressor genes and oncogenes". Statement of the International Symposia of the Princess Takamatsu Cancer Research Fund. (1990) (0)
- [Genetics and cancer]. (1960) (0)
- [Rapid development in tumor biology - a report from a cancer symposium]. (1981) (0)
- Sir Alexander Haddow 1907-1976. (1977) (0)
- Immunology and cancer. (1968) (0)
- Breakdown of ‘Tolerance’ in the Natural Killer Interaction with H-2 Syngeneic Grafts (1989) (0)
- Advances in cancer resarch (2013) (0)
- blood donors Blood donor Diagnosis Extent of disease Age Sex History of transfusion Carcinoma of bladder Carcinoma of bladder and 6 other primary tumors over past 50 yr Melanoma Carcinoma of bladder Carcinoma of bladder Melanoma (2007) (0)
- Prototype NK Target YAC-1 with Antigen Processing ( TAP )-1 / 2 Function Expression , and Poor Transporter Associated the High NK Sensitivity , Low MHC Class I Constitutive IL-10 Production Accounts for Blankenstein and (1998) (0)
- LIMD1, a tumor suppressor at 3p21.3, binds pRb and represses E2F-driven transcription (2004) (0)
- ACUTE GLOMERULONEPHRITIS PRECEDED BY PASSAGE OF URIC-ACID CALCULUS (1978) (0)
- The in vivo coating of tumor cells by potentially cytotoxic antitumor antibodies. (1976) (0)
- No easy despair (1992) (0)
- Restriction of murine leukemia proviral gene expression in somatic mouse cell hybrids. (1980) (0)
- INTERPLAY BETWEEN MITOCHONDRIAL RIBOSOMAL PROTEIN S18-2 AND RETINOBLASTOMA PROTEIN IN REGULATION OF CELL STEMNESS AND DIFFERENTIATION (2015) (0)
- Role of the Recognition of Virion Antigens in the T-Cell Mediated Inhibition of EBV-Induced B-Cell Transformation (1989) (0)
- Solubilization of IgM-kappa specific surface material from Burkitt lymphoma cell lines. (1971) (0)
- Relationship between Allotransplantability and Cell-Surface Glycoproteins in TA3 Ascites Mammary Carcinoma Cells (1979) (0)
- Letter: Hepatitis-B antigen and homologous antibodies in Burkitt's lymphoma and nasopharyngeal carcinoma. (1974) (0)
- Combined treatment with interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha up-regulates the expression of HLA class I determinants in Burkitt lymphoma lines. (1988) (0)
- Detection of Epstein-Barr virus (EBV)-associated nuclear antigen in frozen and thawed cells and subcellular fractions of human lymphoblastoid cell lines by means of an 125I-IgG binding assay. (1975) (0)
- Epstein Barr Virus (EBV) Associated Antibody (Ab) Patterns in Ataxia-Telangiectasia (A-T) (1979) (0)
- Comprar Advances in Cancer Research Volume 100 | George F. Vande Woude | 9780123743589 | Academic Press (2008) (0)
- Studies on cell-mediated reactions against cultured Burkitt lymphoma cells. (1973) (0)
- Immunofluorescence detection of the retinoblastoma protein in mouse fetuses (1992) (0)
- P53 AS SEEN BY AN OUTSIDER (2007) (0)
- I. DEPENDENCE OF CELL MEMBRANE IMMUNOFLUORESCENCE ON PRESENCE OF EB Vmus (2003) (0)
- A microcell hybrid based approach identifies human chromosome 3p genes that are silenced following tumor growth, at four distinct regions (2001) (0)
- Snell, George Davis (1903–1996 (2007) (0)
- The Impact of the Presence of EBV on the Interaction of B Cell Lines with T Lymphocytes (1988) (0)
- Epstein-Barr Virus-specific Leukocyte Migration Inhibition Reaction with Tumor Biopsy Extracts : Correlation with the Presence of Viral DMA 1 (2006) (0)
- Torbjörn Caspersson: some personal perspectives. (1984) (0)
- [Experimental analysis of anti-tumor cytotoxic mechanism for hybrid resistance to mouse neuroblastoma]. (1990) (0)
- Drosophila homolog of the murine Inti protooncogene ( evolutionary conservation of oncogenes / DNA sequence ) (0)
- Comparative genomics of an evolutionary breakpoint region regularly deleted in human tumors (2003) (0)
- Hepatitis-B antigen and homologous antibodies in Burkitt's lymphoma and nasopharygneal carcinoma. (1974) (0)
- 88 Leukotriene B4 Contributes to T Cell Mediated Inhibition of B Cell Growth in the EBV Infected Cord Blood Mononuclear Cell Cultures (2007) (0)
- Light and heavy chains specifying a human IgM kappa autoantibody to a T-cell receptor V beta-antigen. (1993) (0)
- Epstein-barr virus (EBV)-associated antibodies in a case of Burkitt's lymphoma during 14 years of sustained remission (1980) (0)
- Advances in HER , . . , 2 / neu Protein : A Target for CANCER RESEARCH Volume 71 (2008) (0)
- Natural Resistance against H-2+ and H-2− Tumor Cells Grafted to the Brain (1989) (0)
- [Cell membrane receptor of cultured cells derived from nasopharyngeal carcinoma, Burkitt's lymphoma and infectious mononucleosis]. (1971) (0)
- lymphoma-, and in NK-lymphoma derived cell lines protein-1 (LMP-1) in the absence of EBNA-2 in B-lymphocytes, in Burkitt IL-10 can induce the expression of EBV-encoded latent membrane (2013) (0)
- Analysis of multistep scenarios in the natural history of human or animal cancer (1987) (0)
- The Role of EBV in the Etiology of Burkitt’s Lymphoma (BL) (1979) (0)
- Request for specimens from organ transplant and immunodeficiency patients who developed lymphomas. (1979) (0)
- Studies on the nucleic acid content of mouse ascites tumor cells under different experimental conditions. (1951) (0)
- [Cytotoxic effector mechanism and genetic control of non-immunized hybrid resistance to mouse T cell lymphoma transplanted outside and inside the brain]. (1990) (0)
- Linear Association Between Cellular DNA andEpstein-Barr VirusDNA inaHumanLymphoblastoid CellLine (provirus/Raji cells/density gradient centrifugation/nucleic-acid hybridization) (1973) (0)
- [The 1980's: cancer research-a wonderland]. (1979) (0)
- Blood-2011-Kis-165-74 Suppl (2013) (0)
- Proceedings: A circulating cell membrane-related autoantigen-autoantibody system in human sera. (1975) (0)
- Snell, George Davis (2001) (0)
- into an ''Ascites Tumor'' The Transformation of a Solid Transplantable Mouse Carcinoma (2013) (0)
- [Molecular analysis of relationship between oncogene (N-myc and c-src) expression and major histocompatibility complex antigen gene expression in mouse neuroblastoma lines]. (1990) (0)
- Surface marker characterization of EBV-carrying cells in blood of healthy seropositive individuals. (1988) (0)
- Immunological studies on Burkitt's lymphoma. Leukemia Research Fund Lecture. (1971) (0)
- Autoradiographic detection of the Epstein-Barr virus (EBV)-associated early antigen (EA) in lymphoblastoid cell lines. (1977) (0)
- [Leukocyte migration inhibition elicited by Epstein-Barr virus antigen. Reaction potential in infectious mononucleosis as well as in states of immune deficiency and immunosuppression]. (1982) (0)
- K562, an early erythroid or granulocytic cell line (1979) (0)
- Carcinoma into an “Ascites Tumor†(2016) (0)
- Serum anti-EBV IgA is inversely related to tumor infiltration by surface IgA positive lymphocytes in nasopharyngeal carcinoma. (1983) (0)
- Human T-cell leukemia virus-associated nuclear antigen (HTLV-NA). (1986) (0)
- Atlas of Genetics and Cytogenetics in Oncology and Haematology Immune and non-immune surveillance in cancer (2013) (0)
- BLOOD The Journul of The American Society of Hematolog VOL 80 , NO 2 JULY 15 , 1992 EDITORIAL Epstein-Barr Virus-Carrying Cells in Hodgkin ’ s Disease (2003) (0)
- A N T I G E N I N H Y B R I D Cells* (2003) (0)
- Perspectivesin CancerResearch Conditioned Tumorigenicity of Activated Oncogenes 1 (2006) (0)
- A LINK BETWEEN THE EVOLUTIONARY HISTORY OF MITOCHONDRIAL RIBOSOMAL PROTEINS OF S18 FAMILY AND GLY132 POLYMORPHISM IN COLON CANCER (2015) (0)
- 148 Towards a genetics of cancer resistance (2009) (0)
- The Tomizo Yoshida Prize. (1993) (0)
- [Abnormal specificities of immune alloantisera]. (1977) (0)
- An Epstein-Barr Virus-Determined Nuclear Antigen Encoded by a Region within the EcoRI a Fragment of the Viral Genome (1985) (0)
- Structure andExpression ofB-myc, a New Memberof themyc GeneFamily (1988) (0)
- Genetic studies on natural resistance to moloney lymphoma (YAC) isografts (1985) (0)
- Forward and reverse changes in Ig/myc translocation carrying tumors. (1989) (0)
- Changes in the Differentiation Level of Transplanted Tumours (1953) (0)
- Cell-mediated Immune Reactions in Three Patients with Malignant Lymphoproliferative Diseases in Remission and Abnormally High Epstein-Barr Virus Antibody Titers 1 (2006) (0)
- Immunogenicity of tumor cells modified by trinitrobenzene suflonic acid (TNBS). (1976) (0)
- O-9-129 Natural resistance against tumors grafted into the brain in association with histocompatibility-class-I-antigen expression (1997) (0)
- Interaction of EBV Genes with Human Epithelial Cells (1991) (0)
- Immunological studies on Burkitt ' s lymphoma 155 Inducing Cancer , Implications for Therapy (2008) (0)
- [Molecular analysis of mouse major histocompatibility complex class I gene expression of tumors growing in the brain]. (1989) (0)
- EVB-associated immune complexes and recurrent Burkitt's lymphoma. (1978) (0)
- Epithelial characteristics of tumor cells in nasophasyngeal carcinoma. (1976) (0)
- HostCell-Dependent Regulation ofGrowthTransformation- Associated Epstein-Barr VirusAntigens inSomatic CellHybrids (1989) (0)
- Comparison of humoral and cell-mediated responses and virus markers in herpesvirus-associated lymphomas: a review. (1978) (0)
- Brief communication: circulating antigen-antibody complex associated with Epstein-Barr virus in recurrent Burkitt's lymphoma. (1973) (0)
- C H R O M O S O M a L T R a N S L O C a T I O N S a C T I V a T I N G Myc (2003) (0)
- Significance of specific chromosomal translocations and trisomies for the genesis of murine and human tumors of the lymphocyte-plasmacyte lineage. (1983) (0)
- Molecular Characterization ofNovelReciprocal Translocation t(6;14) inanEpstein-Barr Virus-Transformed (1987) (0)
- Strain-related cellular mechanisms as a determinant for susceptibility and resistance to PC induction. (1995) (0)
- 39. Involvement of the retinoblastoma (Rb) protein in the regulation of ceil differentiation (1992) (0)
- Letter to the editor (0)
- Schematic view on the role of HIF1A in EBV-infected B-cell. (2013) (0)
- The DNA Demethylating Agent 5-Azacytidine Induces the Expression of EBNA 2–6 and LMP in Burkitt Lymphoma Lines (1989) (0)
- Chromosomes and morphology in hybrid tumours. (1972) (0)
- Expression of the EBV-Encoded Membrane Protein (LMP) in Virally Transformed Cells (1987) (0)
- Dogma or debate? (1997) (0)
- Advances in Cancer Research (1936) (0)
- The Effect of TGFβ on the Growth of Burkitt Lymphoma and Lymphoblastoid Cell Lines (1990) (0)
- Role of histocompatibility antigen gene and protooncogene expressions in intracerebral tumorigenicity of mouse neuroblastoma. (1993) (0)
- Epstein–Barr Virus (2013) (0)
- Tumor-Host Cell Hybrids in Radiochimeras 149 Chromosome Preparations (2003) (0)
- Effects of dimethyl sulfoxide (DMSO) treatment on H-2 expression and susceptibility to NK and CTL mediated lysis of YAC-1 lymphoma and its β2microglobulin (β2M) deficient variant (1988) (0)
- Epstein-Barr virus-regulation studies on somatic-cell hybrids derived from the fusion of Burkitt's lymphoma and nasopharyngeal carcinoma cells with human or mouse partners. (1978) (0)
- [Can lymphoma be cured by antibiotics?]. (1996) (0)
- Chromosome abberation and oncogene activation in two histologically related human and rat B-cell tumors (2015) (0)
This paper list is powered by the following services:
Other Resources About George Klein
What Schools Are Affiliated With George Klein ?
George Klein is affiliated with the following schools:
